The QualityStocks Daily Friday, December 20th, 2019

Today's Top 3 Investment Newsletters

SmallCapRelations (PBIO) +779.17%

QualityStocks (PRHL) +40.91

StocksToBuyNow (VPRB) +25.81%

The QualityStocks Daily Stock List

BHPA, Inc. (BHPA)

Crypto New Media, CryptoCurrencyTalk, Penny Stock Hub, TipRanks, Cryptopys, Crypto Feed, Stockopedia, MrCoinPedia, The Next Daily, Stockhouse, Stockwatch, Otc.watch, OTC Markets, and Dividend Investor reported earlier on BHPA, Inc. (BHPA), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

BHPA, Inc. is an emerging leader in the cryptocurrency cloud mining marketplace. The Company is taking advantage of its strong cloud hash power and big data processing capabilities toward the creation of a reliable and convenient cloud hash power service platform. The Company previously went by the name Star Resorts Development, Inc. It changed its name to BHPA, Inc. in June of this year. BHPA is headquartered in Chengdu, China.

The Company's wholly-owned subsidiary is BHP Advance, Inc. BHP Advance acts as the technology and service operator and is centered on providing a cryptocurrency mining SaaS (Software as a Service) platform powered by a reliable and secure blockchain algorithm, along with market-leading data processing capabilities and other online services.

Currently, BHP Advance has a well-established international partnership network with several large-scale cryptocurrency mining farms, including RenRenmine Farms. BHP Advance’s commitment is to providing a cloud mining solution that can break new barriers in the cryptocurrency mining space, allowing crypto mining firms and enthusiasts to transcend the defining limitations of time, power, and technology horizon.

This past August, BHPA issued a letter to shareholders on its crypto cloud mining strategy. Wenjie Wu, Chief Executive Officer, said that BHPA does not seek to speculate on the fluctuations that drive so much interest in the cryptocurrency marketplace. However, the Company does seek to profit from the millions of people - private entrepreneurs and large firms - that do, especially when it comes to hashing out mining gains for large and popular coins, including Bitcoin.

Wenjie Wu further noted that BHPA is providing a service for miners, rather than acting as a miner. Therefore, the Company’s results should be far less volatile than those of a miner now that BHPA has seen a strong recovery in Bitcoin prices. According to the Company’s analysis, the most efficient mining operations are profitable above $5,000/Bitcoin at this stage, while far less efficient miners are profitable above $8,000. With Bitcoin now well above $10,000, BHPA expects a sustained growth in mining interest, forming a highly productive context for the Company’s overall market strategy.

BHPA, Inc. (BHPA), closed Friday's trading session at $1.3856, up 6.5846%, on 300 volume with 2 trades. The average volume for the last 3 months is 909 and the stock's 52-week low/high is $0.075000002/$9.64999961.

Copper Mountain Mining Corporation (CPPMF)

Stock Pulse, Streetwise Reports, Wallmine, Trade Ideas, OTC Dynamics, Mining.com, Silicon Investor, Barchart, Dividend Investor, YCharts, Northern Miner, Trading View, Wallet Investor, Stockwatch, The Online Investor, MarketWatch, Street Insider, TeleTrader, Barchart, Stockhouse, GuruFocus, and InvestorsHub reported previously on Copper Mountain Mining Corporation (CPPMF), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Copper Mountain Mining Corporation operates as a mining company in Canada. It explores for copper, gold, and silver deposits. The Company’s flagship asset is the 75 percent owned Copper Mountain mine situated in southern British Columbia near the town of Princeton. Formed in 2006, Copper Mountain Mining is based in Vancouver, British Columbia and the Company lists on the OTC Markets.

At present, the Copper Mountain mine produces roughly 90 million pounds of copper equivalent, with average annual production expected to increase to greater than 110 million pounds of copper equivalent next year. In addition, the Company has the permitted, development-stage Eva Copper Project in Queensland, Australia. Copper Mountain Mining also has an extensive 4,000 km2 highly prospective land package in the Mount Isa area.

The expectation is that the Copper Mountain mine will have a 26 year mine life and produce an average of 116 million pounds of copper equivalent per year (with a modest mill expansion and integration of New Ingerbelle). Furthermore, the permitted development-ready Eva Copper Project in Queensland, Australia is expected to contribute an additional roughly 100 million pounds of copper equivalent per year when in production.

Recently, Copper Mountain Mining announced that it expanded Copper Mountain Mine's (CMM’s) Mineral Reserve and Mineral Resource. The Company has also optimized the mine plan resulting in a lower strip ratio, longer mine life, as well as smoother production profile. All metrics are on a 100 percent project basis.

Highlights from the updated mine plan and Mineral Reserve and Mineral Resource include increased Proven and Probable Mineral Reserve by 12 percent to 477 million tonnes for contained metal of 2.47 billion pounds of copper and 1.55 million ounces of gold (at average grades of 0.23% Cu and 0.10 g/t Au). The life of mine strip ratio was decreased to 1.58 from 1.82. The mine life increased by 4.5 years to 31 years at present planned production levels.

Copper Mountain Mining Corporation (CPPMF), closed Friday's trading session at $0.51, off by 0.874636%, on 11,776 volume with 9 trades. The average volume for the last 3 months is 16,540 and the stock's 52-week low/high is $0.40349999/$0.879999995.

Emmaus Life Sciences, Inc. (EMMA)

Zacks, Stock Twits, BioSpace, iWatch Markets, The Stock Market Watch, OTC Markets, Macrotrends, Street Insider, Market Chameleon, Simply Wall St, TipRanks, Dividend Investor, TradingView, Nasdaq Trader, Seeking Alpha, and PR Newswire reported earlier on Emmaus Life Sciences, Inc. (EMMA), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Emmaus Life Sciences, Inc. is a leader in sickle cell disease treatment. It is a commercial-stage biopharmaceutical company engaged in the discovery, development, marketing and sale of unique treatments and therapies. This includes those in the rare and orphan disease categories. Established in 2000, Emmaus Life Sciences lists on the OTC Markets’ OTCQB. The Company is based in Torrance, California.

While Emmaus’ emphasis has been on rare and orphan diseases, such as sickle cell disease, the Company is now extending its efforts to include conditions and diseases affecting larger populations, such as diverticulosis. Emmaus Life Sciences’ lead commercial product is Endari®. This is an oral pharmaceutical grade L-glutamine treatment indicated to decrease acute complications of sickle cell disease in adult and pediatric patients five years of age and older. Endari is available by prescription only.

Regarding diverticulosis, limited clinical observations have shown that Endari may be effective in treating diverticulosis by slowing or stopping the progression of the disease to diverticulitis. The Company started a small pilot trial in the first half of this year to study the potential use of l-glutamine as a new treatment for patients with diverticulosis.

Concerning Cell Sheet Engineering, Emmaus Life Sciences and CellSeed, Inc. are working jointly to develop and commercialize regenerative corneal epithelial sheets in the USA. This is a technology called “Cell Sheet Engineering”, which has restored the vision of patients with limbal stem cell deficiency in clinical trials conducted in Europe. With this agreement, Emmaus and CellSeed will conduct clinical trials to seek Food and Drug Administration (FDA) approval for use by patients in the U.S.

Last month, Emmaus Life Sciences reported continuing growth and improved financial results for the quarter and nine-months ended September 30, 2019. Net Revenues for the 2019 Q3 rose 25 percent to $6.1 million, up from $4.9 million for the same period last year, and increased 4 percent from the quarter ended June 30, 2019.

This increase was driven chiefly by the continuing roll-out and market acceptance of Endari® in the U.S., the first treatment approved by the FDA for sickle cell disease (SCD) in almost two decades. Net Revenues for the first nine months of 2019 rose 110 percent to $17.3 million, up from $8.2 million in the same period the year prior.

Emmaus Life Sciences, Inc. (EMMA), closed Friday's trading session at $1.99, even for the day, on 36,999 volume with 45 trades. The average volume for the last 3 months is 26,204 and the stock's 52-week low/high is $1.33000004/$12.9071998.

Lixte Biotechnology Holdings, Inc. (LIXT)

Small Cap Network, BioSpace, Street Insider, Wallet Investor, 4-Traders, YCharts, OTC Markets, Stockopedia, Dividend Investor, PR Newswire, Research and Markets, Simply Wall St, Last10k, Market Screener, InvestorsHub, MarketBeat, Stockhouse, Morningstar, and Stockwatch reported earlier on Lixte Biotechnology Holdings, Inc. (LIXT), and today we report on the Company, here at the QualityStocks Daily Newsletter.

OTCQB-listed, Lixte Biotechnology Holdings, Inc. operates as a drug discovery company. It uses biomarker technology to identify enzyme targets related with serious common diseases and designs novel compounds to attack those targets. Its product pipeline is primarily focuses on inhibitors of protein phosphatases, used alone and in combination with cytotoxic agents and/or X-ray and immune checkpoint blockers. A clinical-stage pharmaceutical company, Lixte Biotechnology Holdings is headquartered in East Setauket, New York.

Lixte Biotechnology has identified molecular signaling pathways altered in disease states and designed compounds that can safely target them in animal models. The Company’s present drug portfolio includes inhibitors of serine/threonine protein phosphatases critical to cell division and DNA damage repair and inhibitors of protein deacetylases, which regulate pathways of gene expression and protein degradation.

The phosphatase inhibitors enhance the effectiveness of cytotoxic anti-cancer drugs in general and radiation therapy. This makes them potentially useful for the treatment of numerous cancers in combination with existing standard chemotherapy regimens and with the developing targeted cytotoxic therapies of personalized cancer medicine.

In a pre-clinical study done with scientists under collaborative research and development (R&D) agreements at the National Institutes of Health, Lixte Biotechnology’s lead compound, LB-100, enhanced the antitumor activity of a major immune checkpoint inhibitor. Therefore, this raises the possibility that in addition to improving the efficacy of standard cytotoxic anti-cancer drugs, Lixte’s phosphatase inhibitors may potentiate immunotherapy regimens (Ho 2017).

Earlier this month, Lixte Biotechnology announced that the National Cancer Institute (NCI) enrolled the first two patients of a planned eight patient pharmacologic study of the ability of its lead compound, LB-100, to enter the brain and penetrate recurrent brain tumors in patients where surgical removal of the cancers is indicated (clinical trials registry NCT03027388). The study is being conducted by NCI under a Cooperative Research and Development Agreement (CRADA) with Lixte Biotechnology.

The design of the NCI study is to determine the extent to which LB-100 enters recurrent malignant gliomas. Patients having surgery to remove one or more tumors will receive one dose of LB-100 before surgery and have blood and tumor tissue analyzed for the amount of LB-100 present and to ascertain whether the cells in the tumors show the biochemical changes expected to be present if LB-100 reaches its molecular target. The objective is to acquire data in up to eight patients.

Lixte Biotechnology Holdings, Inc. (LIXT), closed Friday's trading session at $0.70, even for the day, on 32,450 volume with 8 trades. The average volume for the last 3 months is 2,887 and the stock's 52-week low/high is $0.649999976/$1.45000004.

NexTech AR Solutions Corp. (NEXCF)

Zacks, Wall Street Reporter, Streetwise Reports, TipRanks, Stock Day Media, Financial Buzz, Financial Insiders, OTC Markets, Proactive Investors, Morningstar, Spotlight Growth, Otc.watch, Barchart, Investors Hangout, and Wallet Investor reported beforehand on NexTech AR Solutions Corp. (NEXCF), and we also highlight the Company, here at the QualityStocks Daily Newsletter.

NexTech AR Solutions Corp. is the leader in augmented reality (AR) for eCommerce and AR learning applications. The Company has a two-pronged strategy for fast growth including growth via the acquisition of eCommerce businesses and growth of its omni-channel AR SaaS (Software as a Service) platform called ARitize™. NexTech is the first publicly traded “pure-play” AR company, and it commenced trading on the CSE on October 31, 2018. The Company’s shares also trade on the OTC Markets Group’s OTCQB. NexTech AR Solutions has its corporate headquarters in Toronto, Ontario.

The Company has an exclusive license to a portfolio of patents 7,054,831, 7,266,509 and patent-pending applications 15351508, 62457136, 62559487, related to interactive gaming, interactive advertising, and AR technology. NexTech is pursuing four multi-billion dollar verticals in AR - ARitize™ For eCommerce; ARitize™ University; ARitize™ Hollywood Studios; and ARitize™ 3D-AR-360 Advertising Platform.

Regarding ARitize™ For eCommerce, NexTech launched its technologically advanced webAR for e-commerce early in 2019. The Company has been rapidly signing up customers onto its SaaS platform. ARitize™ University launched in June of this year. The app-based solution enables companies and educational establishments to take advantage of all of their existing 2D assets and subsequently overlay immersive 3D-AR experiences on top of that content for an interactive training experience that drives productivity.

Concerning ARitize™ Hollywood Studios, the studio has created a proprietary entertainment venue for which it is producing immersive content using 360 video, and AR as the chief display platform. Regarding ARitize™ 3D-AR-360 Advertising Platform, the ad platform will be the industry's first end-to-end solution where NexTech AR Solutions will leverage it’s 3D asset creation into 3D, 360, and also AR ads.

This week, NexTech AR Solutions announced that Sterilis Solutions, one of the USA’s most innovative medical waste device manufacturers, signed on for NexTech’s WebAR offering and its AR University. This announcement marks the start of a major new use case and opportunity for NexTech’s AR technology in the medical device market. Sterilis will be providing NexTech’s AR learning assets to its top dealers and their sales teams.

Today, NexTech AR Solutions announced that the Company’s 3D augmented reality (3D/AR) solution for eCommerce will integrate seamlessly with Facebook Messenger. The new integration works on desktop computers and mobile phones providing a full screen, device agnostic, web-based 3D/AR experience on Facebook messenger.

Mr. Evan Gappelberg, Chief Executive Officer of NexTech AR Solutions, said, “NexTech’s industry-leading augmented reality eCommerce platform was specifically designed to enhance product engagement, increase add to cart rates and to reduce product returns. Our integration with Facebook Messenger and it’s huge unparalleled ecosystem brings NexTech AR deeper into the eCommerce marketplace and provides an enormous opportunity for more customer wins.”

NexTech AR Solutions Corp. (NEXCF), closed Friday's trading session at $1.52, up 9.3525%, on 175,445 volume with 366 trades. The average volume for the last 3 months is 181,437 and the stock's 52-week low/high is $0.344999998/$2.38798999.

Simlatus Corporation (SIML)

Zacks, Clay Trader, Emerging Growth, Macroaxis, Stock Scores, Financial Insiders, Stockaholics, last10k, Stockwatch, Spotlight Growth, Stock Target Advisor, Financial Buzz, Wallet Investor, Marketbeat, and Real Investment Advice reported previously on Simlatus Corporation (SIML), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Simlatus Corporation focuses on opportunities in the cannabis space. A holding company, it owns and operates several subsidiaries with numerous revenue streams in the CBD (cannabidiol) industry. Proscere Bioscience is the Company’s division focused on the CBD industry. Simlatus Corporation has its head office in Grass Valley, California.

The Company’s diversity includes other subsidiaries, including Satel Group. Satel is a premier high-rise DirecTV provider for the financial commercial and residential metropolitan San Francisco Bay area. Additionally, its subsidiaries include Simlatus, a manufacturer of audio/video products that currently sells to DirecTV, CBS, Fox News and Warner Bros.

Simlatus manufactures and markets commercial High-Definition (HD) and Analog audio/video systems for the global broadcast studio industry. The Company continues to lead the commercial industry with high-end equipment. Its “SyncPal™ and Simlatus-IBS™ are for revolutionizing studio management and audio/video control using smartphones or smart glasses.

Pertaining to the Digital Media and Augmented/Virtual Reality device industry, Simlatus’ SocialCast AR and Augmented/Virtual Reality Content Server products will enable the Company to expand into high-growth digital television and over-the-top (OTT) markets. It is developing technologies in Virtual Reality, Augmented Reality, Audio/Video Codecs, Audio Content Recognition, as well as OTT API Integration.

In November, Simlatus announced that Proscere Bioscience secured the rights to manufacture a CBD - Hybrid Extraction System with integrated cold-water and alcohol extraction technologies. Proscere Bioscience will manufacture the world’s first Hybrid Cold-Water/Alcohol Extraction System for CBD.

Mr. Richard Hylen, Chief Executive Officer of Simlatus, stated, “Having secured the technological rights to build and bring to market the world’s first Hybrid Extraction System for CBD is certainly a game changer for the Company. This Hybrid System will initially process biomass through cold-water extraction, then alcohol extraction via an integrated system that results in very high quality pharmaceutical grade CBD and commercial grade CBD from the same biomass.”

Simlatus Corporation (SIML), closed Friday's trading session at $0.0001, even for the day, on 81,265,548 volume with 47 trades. The average volume for the last 3 months is 131,509,439 and the stock's 52-week low/high is $0.000039999/$0.083999998.

Sonic Foundry, Inc. (SOFO)

NetworkNewsWire, Stock Twits, Zacks, MacroTrends, Street Insider, Whale Wisdom, Market Exclusive, Infront Analytics, Market Chameleon, OTC Markets, and InvestorsHub reported beforehand on Sonic Foundry, Inc. (SOFO), and we also report on the Company, here at the QualityStocks Daily Newsletter.

Sonic Foundry, Inc. is the worldwide leader for video capture, management and streaming solutions. The Company’s Mediasite Video Platform quickly and cost-effectively automates the capture, management, delivery and search of live and on-demand streaming videos. This Platform is trusted by greater than 5,200 educational institutions, corporations, health organizations and government entities in more than 65 countries. Established in 1991, Sonic Foundry has its corporate office in Madison, Wisconsin.

In essence, Mediasite is a video platform with the power to transform how people learn, communicate, collaborate, and ultimately excel. Mediasite is the most automated and scalable video platform for every facet of one’s video deployment. A user can capture, edit, share, search and manage videos in one secure place. The average Mediasite customer generates over 4 million hours of content annually.

Moreover, Mediasite is the longest–running educational video platform on the market. Students watch Mediasite more than any other platform. In addition, instructors produce high-quality lectures and videos, and active learning is supported with quizzes, annotations, comments, as well as discussions.

This past October, Mediasite announced powerful new features that give users better control over how students experience video lectures. This ensures the most impactful, data-rich and searchable study tools for all.

Mediasite has speech-to-text integration with IBM Watson and automated closed captioning capabilities to create full content search for everything said and shown in numerous languages, automatically indexing it and removing vocal pauses for cleaner transcripts. Faculty and students contribute to the more than 110 million views of the 2 million videos created with Mediasite each year.

A new confidence score feature ensures the speech-to-text in Mediasite is accurate before displaying it as captions on a video. Moreover, the Mediasite player and larger video libraries are also screen reader compatible. Additionally, Mediasite allows for magnification within the player for the hearing and visually impaired. Enhancements to Mediasite Monitor, a Mediasite Recorder management tool, permit users to preview the output of up to 16 devices at the same without latency. Users can hear the audio preview and triage any potential audio issues.

Sonic Foundry, Inc. (SOFO), closed Friday's trading session at $1.28, up 10.3448%, on 33,804 volume with 51 trades. The average volume for the last 3 months is 3,487 and the stock's 52-week low/high is $0.600000023/$1.76499998.

Sino United Worldwide Consolidated Ltd. (SUIC)

StockAlert, Penny Stock Hub, Real Investment Advice, Investor News, Wallet Investor, MarketBeat, MarketWatch, Simply Wall St, Stockwatch, Global Banking and Finance, Stockopedia, Infront Analytics, Last10k, TMXmoney, GlobeNewswire, Stockhouse, InvestorsHub, and Morningstar reported earlier on Sino United Worldwide Consolidated Ltd. (SUIC), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Sino United Worldwide Consolidated Ltd. is a FinTech (Financial Technology) company. It provides Venture Financing and Blockchain services to five sectors. These include “Logistics & Trade”, “Vehicle & Transportation”, “Finance & Coin”, and “Medical & Healthcare”, and a new addition, “FinTech.” The Company previously went by the name AJ Greentech Holdings Ltd. It changed its name to Sino United Worldwide Consolidated Ltd. in July of 2017. Established in 2009, the Company is based in Flushing, New York. Sino United’s Asian operating center is located in Hong Kong and Singapore.

The Company’s primary business is in Blockchain, in 4 Sectors. These are Blockchain in Logistics and Trade; Blockchain in Vehicle and Transportation; Blockchain in Finance And Coin; and Blockchain in Medical and Healthcare. The addition of the FinTech sector to Sino United’s Blockchain services includes a complete update in which the Company will build up its own internal capabilities through actively starting a Blockchain training program, developing a 3rd generation Smart Contract Blockchain under the Sino United brand, and using these capabilities to provide a comprehensive ICO consultancy.

In December of 2018, Sino United Worldwide Consolidated and USADAE (American Digital Asset Exchange) revealed the Joint Venture (JV) to launch the new FinTech trading platform, embarking on the first worldwide Blockchain conglomerate as a hub for innovative Blockchain technology and unique Blockchain projects. The partnership adjoins the sanctioned practices of regulated and inventive finance and exchanges and the present flourishing digital world enabled by Blockchain, Distributed Ledger and Artificial Intelligence (AI) technologies.

This Sino United-USADAE alliance offers clients security and storage services, and also trade execution for crypto, digital assets. The alliance will merge their strong trading platform technology and premium selection of digital tokens, adopting rigorous assessment utilizing the latest in proof-of-reputation algorithms and other advanced programs.

Recently, Sino United Worldwide Consolidated announced that it and iDrink Technology Co. Ltd., Taiwan signed a Share Exchange Agreement (SEA) to work together on the distribution of iDrink Smart IoT (Internet of Things) Vending Machines in the global market. Upon closing of this SEA, Sino United will acquire a 20 percent stake in iDrink in exchange for delivery, by Sino United to iDrink, of 1,000,000 Sino United Worldwide Consolidated restricted common shares.

Upon closing, Sino United’s plan is to assist iDrink in developing its marketing plans and to implement strategic marketing alternatives internationally. Sino United’s belief is that this interaction is a major milestone, which will provide new growth opportunities for Sino United and iDrink, combining the complementary strengths to become a laterally positioned provider of smart IoT vending solutions.

Sino United Worldwide Consolidated Ltd. (SUIC), closed Friday's trading session at $2.00, up 83.4862%, on 200 volume with 2 trades. The average volume for the last 3 months is 129 and the stock's 52-week low/high is $1.09000003/$5.00.

Jacksam/Convectium Corporation (JKSM)

NetworkNewsWire, Stock Target Advisor, Stockwatch, Simply Wall St, InvestorsHub, Real Investment Advice, Investors Hangout, Stockhouse, and Trading View reported previously on Jacksam/Convectium Corporation (JKSM), and today we choose to highlight the Company, here at the QualityStocks Daily Newsletter.

Jacksam/Convectium Corporation is a workflow automation company. It concentrates on developing solutions in the cannabis and CBD (cannabidiol) industry. The Company designs and markets proprietary automated vape cartridge filling/capping equipment for the cannabis industry. Established in 2013, Jacksam/Convectium has its corporate office in Rancho Santa Margarita, California.

The Company’s automated equipment line is designed and built in the United States. In addition, it carries full UL certification. Using Convectium's automated equipment, Jacksam/Convectium customers are able to boost their output by up to 60 times over hand filling.

Convectium is focused on helping its customers automate their workflow and get custom branded products onto dispensary shelves and into the hands of customers faster. Greater than 100 companies, including many major brands in the space, rely on Convectium for automation of their filling operations. Convectium has operations in seven U.S. cities, utilizes two factories in the U.S., as well as three dedicated factories in Shenzhen, China. Convectium has more than 25 employees.

A technology enterprise, the Company centers on developing and commercializing products using a proprietary technology platform. Jacksam/Convectium’s main products include 710 Shark cartridge filling machines, 710 Captain cartridge capping machines, and cartridge and disposable vaporizers. The Company serves the medical cannabis, hemp, and CBD segments of the e-cigarette and vaporizer markets with its oil vaporizer focused products.

Jacksam/Convectium’s Shark automated filling machine is on its eighth engineering version. It has proven to be a very reliable product for the Company. Many of the changes to its equipment have been the result of direct customer feedback. The Company is also developing a new U.S. manufactured line with advanced electronics and full UL certification.

Recently, Jacksam/Convectium announced that Mr. Robert Hagen joined its Board of Directors. Mr. Hagen is also a Director of DMO Holdings, which is a private company providing research services in the cannabis industry. Moreover, since August 2018 he has served as the Chief Executive Officer of Jujube International, Inc. Jujube is an international leader in direct to consumer sales of motherhood accessories, including diaper bags and other related products.

Jacksam/Convectium Corporation (JKSM), closed Friday's trading session at $0.43, up 53.5166%, on 450 volume with 2 trades. The average volume for the last 3 months is 1,768 and the stock's 52-week low/high is $0.25999999/$3.20000004.

Dream Homes & Development Corporation (DREM)

Stockhouse, InvestorsHub, Morningstar, TradingView, Digital Journal, YCharts, Wallet Investor, Wall Street Analyzer, Stockwolf, Wallstreet-Online, Penny Stock Hub, Stockwatch, Dividend Investor, Barchart, Simply Wall St. and Investors Hangout reported earlier on Dream Homes & Development Corporation (DREM), and today we are highlighting the Company, here at the QualityStocks Daily Newsletter.

Dream Homes & Development Corporation is a fully integrated real estate company listed on the OTC Markets’ OTCQB. Licensed new home builders and general contractors, Dream Homes is building, raising, renovating and reconstructing homes up and down the New Jersey shore area. Established in 2009, and a full-service construction company, Dream Homes & Development is based in Forked River, New Jersey.

Dream Homes & Development is equipped to complete all facets of a building project. This includes design, architectural, engineering, and construction. The Company is a full-service building and development enterprise that operates chiefly in the coastal areas of New Jersey.

Dream Homes & Development provides an array of services and products. These include land development and approvals, infrastructure installation, new single and multi-family construction, engineering & structural design, soil studies, architectural and design/build capabilities, and construction management services.

Services and products provided additionally include general contracting of all residential single and multi-family construction, helical and timber pile installation, masonry foundations and concrete work of all varieties, management of home elevation and moving projects and complete finish requirements for all interior construction.

Dream Homes has successfully completed over 1,500 new homes and more than 200 elevation projects. The Company is contracted to develop and construct a 60-unit town home development in Lacey Township, New Jersey over the next two years valued at $12 to $14 million.

At present, Dream Homes & Development has a number of new home properties under contract and in development. These new developments include 13 single family homes, 58 townhomes and 68 waterfront townhomes, all in the Ocean County region of New Jersey.

Dream Homes & Development has its new Modular Division in Point Pleasant, New Jersey. The office and showroom in Point Pleasant allows Dream Homes to better serve the northern Ocean/southern Monmouth region of New Jersey. It complements the main office in Forked River. The showroom offers a complete kitchen, bath, flooring, as well as finish design center. The new Design Center in Point Pleasant has led to growth in modular traffic and sales. In addition, it has facilitated and increased client selections throughout the Company’s entire region.

Dream Homes & Development has completed the acquisition of Premier Modular Homes. Premier has a 23-year record of accomplishment serving southern Ocean County with a focus on Long Beach Island. On October 20, 2018, Dream Homes acquired a substantial portion of the assets of Premier Modular Homes, located in Little Egg Harbor, New Jersey. The acquired assets include physical and intellectual property (IP), such as phone numbers, web site, use of the Premier Modular Home name, equipment, vehicles and trailers. Furthermore, the Company leased the physical premises. This includes the office, showroom, garage, as well as yard space.

Dream Homes & Development Corporation (DREM), closed Friday's trading session at $0.12, up 59.5745%, on 200 volume with 2 trades. The average volume for the last 3 months is 1,930 and the stock's 52-week low/high is $0.075199998/$0.219999998.

Oncolix, Inc. (ONCX)

NetworkNewsWire, Stock News Now, Stockhouse, Penny Stock Hub, SmallCapVoice, Stockwatch, OTC Markets, Marketwired, The Street, Dividend Investor, Investopedia, Barchart, Stockopedia, and InvestorsHub reported earlier on Oncolix, Inc. (ONCX), and today we are reporting on the Company, here at the QualityStocks Daily Newsletter.

Oncolix, Inc. is developing Prolanta™ for the treatment of ovarian, uterine, breast, and other cancers. Oncolix has a US FDA-cleared (Food and Drug Administration) IND to begin human testing of Prolanta™ in its first indication, the treatment of ovarian cancer. The Phase 1 clinical trial is now in progress. A clinical-stage biotechnology company, Oncolix has its corporate office in Houston, Texas. The Company lists on the OTCQB.

Oncolix believes Prolanta™ has the opportunity to treat a broad spectrum of human cancers. It states that there is substantial scientific evidence that human prolactin is associated with the growth of many cancers and also the development of resistance to common chemotherapies. Oncolix believes Prolanta™ will be effective against manifold cancers as a stand-alone therapy and also as part of combination therapy.

Prolanta™ is a prolactin receptor antagonist (or blocker). Prolanta™ has demonstrated efficacy in xenograft models by way of an innovative mechanism of action, autophagy. There is strong preclinical evidence Prolanta™ may be effective in breast, prostate, and other cancers, in addition to ovarian cancer.

Prolanta™ is undergoing evaluation in an open-label dose escalation Phase 1 clinical trial in patients with advanced ovarian cancer. Patients are divided into three dosing groups (cohorts). Each sequential cohort will evaluate a higher dose of Prolanta™. In the current Phase 1 dose-escalation safety trial for the treatment of ovarian cancer, so far there have been no observed serious adverse events. In addition, there have been no dose-limiting toxicities. The FDA has approved the designation of Prolanta™ as an Orphan Drug for the treatment of ovarian cancer.

Oncolix announced in January 2018 that it sponsored additional research with MD Anderson Cancer Center. This research will evaluate Prolanta™ for the potential treatment of additional gynecological cancers, more specifically uterine cancer.

This past September, Oncolix announced that it entered into a non-binding Letter of Intent (LOI) for an exclusive worldwide license agreement from IGL Pharma, Inc., (IGLP) for a novel drug for the potential treatment of osteosarcoma, bone metastases and bone marrow ablation. The Proposal includes all uses for the drug, a radiopharmaceutical, Samarium-153 DOTMP (CycloSamTM).

Recently, Oncolix announced that it finalized its license agreement from IGL Pharma, Inc., (IGLP) for a novel, clinical stage drug for the treatment of osteosarcoma.

Mr. Michael Redman, Oncolix Chief Executive Officer, said, ''We are pleased to license this very exciting drug candidate. While our first target will be osteosarcoma, we plan to expand its use into bone metastases and bone marrow ablation, two additional large potential markets. Oncolix now has two promising oncology drugs in clinical stages.''

Oncolix, Inc. (ONCX), closed Friday's trading session at $0.0001, up 9,900.00%, on 149,000 volume with 3 trades. The average volume for the last 3 months is 680,281 and the stock's 52-week low/high is $0.000000999/$0.0161.

Rennova Health, Inc. (RNVA)

Small Cap Stocks, Awesome Penny Stocks, The Street, Street Insider, StockTwits, Barchart, Uptick Newswire, Investors Hangout, ClayTrader, Capital Cube, Preferred Stock Channel, CannabisNewsBreaks, InvestorsHub, and Stockhouse reported on Rennova Health, Inc. (RNVA), and today we report on the Company, here at the QualityStocks Daily Newsletter.

Rennova Health, Inc. is a vertically integrated provider of industry-leading diagnostics and supportive software solutions to healthcare providers. The Company is a single-source healthcare solutions company. Rennova Health opened its first rural hospital in Oneida, Tennessee on August 8, 2017. Listed on the OTC Markets, Rennova Health is based in West Palm Beach, Florida.

Medytox Diagnostics is a subsidiary of the Company. In addition, Rennova Health has its comprehensive medical billing services company, Medical Billing Choices (MBC). MBC operates as the in-house billing company for all Rennova Health businesses and labs.

Rennova Health concentrates on serving essential healthcare categories, particularly those with unmet needs and major opportunities for innovation-driven solutions. The Company develops and operates progressive businesses, systems and services to support better treatment outcomes, more cost-effective patient care, and optimized revenue streams.

Rennova Health currently operates in three synergistic divisions. One is clinical diagnostics via its clinical laboratories. The second is supportive software solutions to healthcare providers. This includes electronic health records (EHR), laboratory information systems (LIS), and medical billing services. The third is the recent addition of a hospital in Tennessee.

Rennova Health’s solutions include industry-leading diagnostic laboratory testing and analytics for precision medicine, and specialized and streamlined EHRs and other essential software services. Furthermore, the Company’s solutions include complete medical billing and financial services for enhanced revenue cycle management.

The Company’s Medytox Diagnostics subsidiary owns and operates five high-complexity CLIA-certified labs strategically located across the nation. These labs specialize in urine drug testing for prescription medications, drugs of abuse and complete pain medication testing. The labs also provide testing services in the areas of clinical chemistry, toxicology, hematology, immunology, serology, bacteriology and esoteric testing services, including neurotransmitter testing, with a wide variety of sampling options that include Rennova’s proprietary methodology.

Rennova Health has acquired its second Rural Hospital - an 85-bed hospital in Jamestown, Tennessee. This hospital is known as Tennova Healthcare – Jamestown. It and its associated assets were acquired from Community Health Systems, Inc. (CYH). Moreover, the transaction includes a Jamestown based doctor’s practice and clinic.

Recently, Rennova Health announced completion of installation and training for a state of the art GE LightSpeed VCT 64 slice CT Scanner. The high image resolution and acquisition speed of the new CT scanner is ideal for angiography, cardiac neuro, pediatric, pulmonary and trauma when freezing of cardiovascular motion, pure arterial phase imaging, and superior Multiplanar reformats are vital features. The new CT Scanner will considerably improve patient care and revenue streams.

Rennova Health, Inc. (RNVA), closed Friday's trading session at $0.0001, up 100.00%, on 3,366,454 volume with 32 trades. The average volume for the last 3 months is 60,360,940 and the stock's 52-week low/high is $0.000000999/$0.0019.

REGI U.S., Inc. (RGUS)

Zacks, Morningstar, Marketwired, The Street, MarketWatch, Barchart, OTC Markets and Stockhouse reported earlier on REGI U.S., Inc. (RGUS), and we report on the Company as well, here at the QualityStocks Daily Newsletter. 

REGI U.S., Inc., by way of its subsidiary, RadMax Technologies, Inc., engages in the design and development of axial vane-type rotary engines, known as the RadMax rotary technology, used in the design of engines, compressors, and pumps. RadMax Technologies is developing for commercialization numerous improved axial vane type rotary devices using its Patented RadMax™ Rotary Technology. REGI U.S. is based in Spokane, Washington. 

The RadMax™ Rotary Technology allows for leading-edge designs of lightweight and high efficiency engines, compressors, pumps, and other devices. One current prototype is The RadMax™ engine. It has only two unique moving parts, the vanes (up to 12) and the rotor, in comparison to the 40 moving parts in a basic four-cylinder piston engine. 

The Company’s aim is to license RadMax technology and/or participate in joint ventures (JVs) to manufacture RadMax products for specific applications. Market segments that could benefit from RadMax technology include (but are not limited to) transportation, aerospace, air conditioning and refrigeration, oil and gas production and distribution, power generation, marine, and military markets.

The Board of REGI U.S. and RadMax Technologies announced this past February that a provisional patent application was filed with the U.S. Patent and Trademark Office (USPTO) for the use of RadMax two-phase compressors and expanders to increase the efficiency of Rankine cycle steam electricity generation plants.

Also, in March, The Board of Directors of REGI U.S and RadMax Technologies announced that a provisional patent application was filed with the USPTO for the use of RadMax two-phase compressors and expanders to increase the efficiency of air conditioning and refrigeration cycles.

Earlier in July, The Board of Directors of Regi U.S. and its wholly-owned subsidiary, RadMax Technologies announced the achievement of a significant milestone in the development of the RadMax sliding axial vane gas expander. Ongoing development and testing of the gas expander prototypes have demonstrated overall efficiencies more than 70 percent, a major technical milestone.

The expectation is that future development and testing will further increase efficiencies, into the mid-80 percent range through using more advanced bearings, coatings, and other friction reducing technologies. In addition, testing has shown the device’s power curve as similar to other positive displacement engines and is characterized by a broad peak with high torque.

REGI U.S., Inc. (RGUS), closed Friday's trading session at $0.07, up 33.3333%, on 436,395 volume with 27 trades. The average volume for the last 3 months is 27,445 and the stock's 52-week low/high is $0.0052/$0.119999997.

Premier Holding Corp. (PRHL)

OTC Markets, InvestorsHub, Street Insider, Stockhouse, Investors Hangout, and StockFlare reported on Premier Holding Corp. (PRHL), and we highlight the Company as well, here at the QualityStocks Daily Newsletter.

Premier Holding Corp., by way of its subsidiaries, provides energy efficiency products and services. It does so mainly to commercial middle market companies and residential customers in the U.S. Premier provides financial support and management expertise. This includes access to capital, financing, legal, insurance, mergers, acquisitions, joint ventures (JVs) and management strategies. Listed on the OTCQB, Premier Holding has its corporate office in Tustin, California.

Premier Holding’s companies have wide-ranging experience in technologies and services for deregulated power and expertise in energy reduction. Fundamentally, its companies lower its clients’ price and usage of energy. Premier's mission is to acquire clean technology companies and/or green products and services, which are accretive and that can be seamlessly integrated and use the overall economics of such products and services for the benefit of its customers.

The Company’s holdings include The Power Company and E3 - Energy Efficiency Experts. The Power Company is an experienced energy consulting firm in the deregulation space. It uses its market standing and its large, well-established network of energy suppliers to compete for its clients’ business. The Power Company serves as its clients’ energy advocates. Moreover, it negotiates the most competitive pricing and options for its clients.

The Power Company received the "2017 Leaders Diamond" Award from a major deregulated power supplier. The award combines the volume of sales, connected with the sales of home products. It calculates this with a quality score by customers to create a "Sales Quality" Score. The team at TPC attained the highest score among all resellers for 2017.

E3 - Energy Efficiency Experts is an Energy Services Company (ESCO). E3 was created by Premier Holding to provide the best-of-breed energy reduction solutions for its customers. E3 works to provide the most current, fully-vetted solutions in energy reduction technologies. It also works to provide management tools that capture the client for future opportunities.

Premier Holding has announced that its subsidiary, The Power Company (TPC), supports another large commercial contract. This indicates its breadth of sales into the residential and commercial sectors. TPC continues to help manage and lessen the energy costs for one of the largest and fastest growing physical therapy companies in the nation.

Recently, TPC secured the energy supply for its customer's newest properties in Texas. This helps to manage an important business expense for its customer, while the company continues to expand through organic growth and acquisitions. In addition, this company is in talks to further help reduce its customer's energy costs through the implementation of LED lighting for its locations throughout the country via Premier’s energy efficiency division, E3 - Energy Efficiency Experts.

Premier Holding Corp. (PRHL), closed Friday's trading session at $0.00155, up 40.9091%, on 5,000 volume with 1 trade. The average volume for the last 3 months is 192,321 and the stock's 52-week low/high is $0.00095/$0.019999999.

The QualityStocks Company Corner

SRAX Inc. (NASDAQ: SRAX)

The QualityStocks Daily Newsletter would like to spotlight SRAX Inc. (NASDAQ: SRAX).

SRAX (NASDAQ: SRAX), a digital marketing and consumer data management technology company, today released a new study of over 116,000 Americans revealing this year's holiday spending behaviors and trends. To view the full press release, visit http://nnw.fm/E1UxA. Also today, NetworkNewsWire released a report on the company detailing how privacy and data ownership are the Company’s emphasis. Headquartered in Los Angeles, SRAX focuses on offering consumers the ability to own their data and receive payment for the release of it. SRAX is in the process of building the most valuable opted-in consumer data set in the world.

SRAX Inc.'s (NASDAQ: SRAX) is a digital marketing and consumer data management technology company. SRAX’s technology unlocks data to reveal brands’ core consumers and their characteristics across marketing channels.

Through its BIGtoken platform, SRAX has developed a consumer-managed data marketplace where people can own and earn from their data, thereby providing everyone in the internet ecosystem choice, transparency and compensation.

SRAX’s tools deliver a digital competitive advantage for brands in the CPG, automotive, investor relations, luxury and lifestyle verticals by integrating all aspects of the advertising experience, including verified consumer participation, into one platform.

SRAX Verticals

  • SRAX Core: SRAX Core is a custom digital media management platform that enables brands and agencies to surpass the challenges of omnichannel marketing campaigns. It offers one comprehensive dashboard to manage digital media campaigns, inventory and reporting.
  • SRAX Social: SRAX Social is a free social media management tool that makes it easy for brands, agencies and individuals to grow their digital presence. It offers free and unlimited users, Facebook auto boosting, and a custom analytics dashboard. Its managed services team can also build and execute marketing plans for your unique specific needs.
  • SRAX IR: SRAX IR unlocks stock buyers’ behaviors and trends for issuers of publicly traded companies. The platform provides insights on shareholders and market makers, investor relations management, shareholder outreach tools and data-driven marketing.
  • SRAX Auto: SRAX Auto unlocks auto intenders’ data to create measurable connected experiences on the road to purchase. It offers proprietary auto intender profiles, multi touchpoint communication and custom location-based ads.
  • SRAX Shopper: SRAX Shopper delivers a cross channel, premium digital experience at scale to high value shopper audiences. It offers proprietary shopper profiles, cost per click pricing, and custom text and add to cart ad units.
  • SRAX Lux: Launched in June 2019, the SRAX Lux platform targets and reaches luxury consumers at luxury retail stores, high-end art, music, film, fashion and sports events, across all consumer devices.

BIGtoken

BIGtoken, available for download on the App Store and Google Play, revolutionizes data collection. BIGtoken is a platform that creates a secure and transparent environment for consumers to own and earn from their data. To date, there are 15.9 million BIGtoken registered users worldwide.

The optimization and monetization of data is a multibillion-dollar business. Worldwide spending on big data and business analytics solutions reached $166 billion in 2018 and is projected to surge to $260 billion by 2022. BIGtoken’s consumer vision is committed to delivering choice, transparency and compensation to the individual.

Through BIGtoken, consumers earn rewards when they opt into sharing their data and when that data is purchased. Consumers decide what data is shared, who can buy it and how it’s used, and advertisers reach real, responsive audiences. The benefit of this is two-fold: consumers know how their data is used and advertisers gain verified consumer data for targeting.

Users of the BIGtoken app can officially be paid in cash or gift cards in exchange for giving brands access to their anonymized data, answering questions, checking into locations, recruiting new members, and more. Users can deposit their earnings directly into PayPal accounts or be paid through gift cards from favorite retailers such as Walmart.

SRAX has also partnered with several high-profile, nonprofit associations to provide BIGtoken users the ability to donate their earnings. Partnerships include the American Heart Association, dedicated to fighting heart disease and stroke; HealthCorps, which helps high school students make better choices about health and physical fitness; and the ALS Association, which recently launched its Challenge Me campaign.

International Expansion

BIGtoken is formally launching into several international markets and partnering to foster local support. SRAX recently signed a joint venture with the Yash Birla Group to launch BIGtoken in India. Based in Mumbai, the Yash Birla Group, one of India’s largest conglomerates, has diversified interests in consumer and industrial products.

The partnership will bring BIGtoken’s platform to India, which has a digital population of 627 million. The India digital advertising market is $3.6 billion and is set to grow at a compound annual growth rate of 32%, making it one of the largest growing digital ad markets in the world.

SRAX Mexico is led by Moe Avitia, who has more than 18 years of experience in business development and building high-tech teams. SRAX Mexico includes a team of 90 employees, including 70 engineers.

BIGtoken Europe is currently evaluating data centers in individual countries for privacy laws.

Leadership

Christopher Miglino is CEO and founder of SRAX. He has spent the past 20 years working in the digital advertising space and has successfully launched and sold two internet companies. Both of these companies were sold to publicly traded companies on the NASDAQ. He has a detailed understanding of how technology interacts with brands.

Kristoffer Nelson is COO of SRAX and a founding member of BIGtoken. With over 15 years of technology and creative business experience, Nelson has been a guest speaker for Loyola Marymount University among other academic institutions, the National Association of Broadcasters, the IAB and numerous other professional and media organizations.

SRAX Inc. (NASDAQ: SRAX), closed Friday's trading session at $1.42, up 2.8986%, on 74,786 volume with 195 trades. The average volume for the last 3 months is 119,062 and the stock's 52-week low/high is $1.04999995/$5.8499999.

Recent News

OriginClear (OTC: OCLN)

The QualityStocks Daily Newsletter would like to spotlight OriginClear (OTC: OCLN).

OriginClear (OTC: OCLN), a leading provider of water treatment solutions, was featured on this week’s episode of MoneyTV with Donald Baillargeon. The internationally syndicated program, viewed in over 200 million households in more than 75 countries, covers money-focused topics and features various companies and in-depth CEO and executive interviews offering insights into operations and future outlooks. This week’s program featured OriginClear CEO Riggs Eckelberry and COO Thomas Marchesello as they looked back on 2019 and forward to 2020. To view the full press release, visit http://nnw.fm/Ybl2I.

OriginClear (OTC: OCLN) leads the self-reliant water revolution, deploying advanced technologies at the point of use, with modular, prefabricated systems that create durable assets and water independence for industry, commerce and agriculture.

Failing infrastructure and the rising cost of water are driving businesses to treat their own water. OriginClear leads this megatrend with on-premise systems enabling very high purification and recycling levels that centralized systems cannot achieve.

Systems installed at the point of use become productive assets for businesses that also increase property values. And OriginClear helps corporations improve their environmental, social and governance (ESG) standings with world-class water management.

Operations & Markets

OriginClear leads a new generation of water companies that focus on meeting the needs of businesses looking for compact, advanced technologies that can be shipped to and installed at the point of use. The company manufactures and distributes its professional-grade water treatment and conveyance products to commercial and industrial properties, fielding both direct and indirect sales channels to reach end-market clients such as hotels and resorts, real estate housing developments, office buildings, military installations, schools, farms, food and beverage manufacturers, industrial warehouse, oil and gas producers, and medical and pharmaceutical facilities.

From its Texas-based factory, OriginClear designs and prefabricates an entire line of plug-n-play containerized units called Modular Water Systems™ that enable water purification, recycling and wastewater management.


Industrial Pretreatment Waste Water Treatment Plant (WWTP) designed by Daniel M. Early, using reinforced thermoplastic modules.

These onsite modular products provide clients with water independence through ownership and operational control over water quality, enabling them to increase productivity while reducing environmental, health and safety risks from pollution, contamination and corrosion. Modular water products are trusted to balance performance with cost-effectiveness, enabling business users to go well beyond municipal standards for water quality, therefore achieving high levels of satisfaction for their own customers, and improved sustainability for their properties.

OriginClear’s water treatment equipment can boost real estate asset value as a fundamental capital improvement, combined with long-lasting water savings for the corporate bottom line.

Product Portfolio

OriginClear groups its products into three main categories:

  1. Water Treatment: achieving high grade purification.
  2. Water Conveyance: water transportation and pumping.
  3. Advanced Technologies: commercialization of innovative technologies.

OriginClear’s complete line of compact, on-site, point-of-use products include: advanced purification systems that are skid, rack-mounted and containerized for reverse osmosis, ultrafiltration, media filtration, disinfection, water softening, ion exchange and electrodeionization (EDI), combined as needed in small to medium commercial and industrial applications, and custom-build projects. Water conveyance products include pump and lifting stations, modular storage tanks, and control monitoring panels.

OriginClear’s line of modular water products and systems is key to the self-reliant water treatment revolution as they create “instant infrastructure” – fully engineered, prefabricated and prepackaged systems that use durable, sophisticated materials. The units are available in standard capacities for onsite closed-loop systems at commercial business locations.

The company’s rugged wastewater treatment plants, highly reliable pump stations, and premium water purification units typically offer 25 percent lower initial costs over conventional systems, with greater quality and full connectivity. These pump stations and wastewater treatment products utilize high density thermo-plastics (HDPE) and proprietary, innovative prefabrication methods and materials that deliver the longest life and strongest products.

Breakthrough Technologies

OriginClear has a long history of innovation through its OriginClear Technologies division, which is responsible for identifying leading-edge technologies to solve today’s toughest challenges. These advanced technologies are the centerpiece of the division’s international licensee network. The technologies are developed in OriginClear Technologies, and licensees integrate them into their own products.

Electro Water Separation™ (EWS) and Advanced Oxidation (AOx™) are the principal, well-proven technologies.

EWS is OriginClear’s breakthrough water cleanup technology which utilizes a catalytic process to concentrate and eliminate suspended solids in the worst commercial and industrial wastewater.

AOx is OriginClear’s proprietary advanced oxidation technology which generates a dense cloud of ozone, hydrogen peroxide and hydroxyl radicals, dramatically reducing or eliminating dissolved organic microtoxins, including bacteria and viruses, hormones, drugs, pesticides such as Roundup, and synthetics. AOx has also been shown to effectively reduce harmful chemicals such as ammonia and hydrogen sulfide – the “rotten egg” smell in crude oil that reduces its value.

Through international licensing and partnerships, OriginClear’s advanced technologies are being adopted to treat tough water problems in East and South Asia, Europe and the Middle East, and North America.

Market Opportunity

In just 10 years, the global water services market has doubled into a trillion-dollar industry, driven by improper sanitation and water scarcity. Only 20 percent of all sewage and only 30 percent of all industrial waste are ever treated. Additionally, water leakage results in the loss of 35 percent of all clean water across the planet; reducing that percentage by half would provide clean water for 100 million people. This is a situation of great danger, but also great potential.

The statistics demonstrate that we can no longer rely on the efficiencies of giant, centralized water utilities to meet these challenges. An increasing number of businesses are starting to take notice, instead conducting their own water treatment and recycling. Whether by choice or out of necessity, those businesses that do invest in onsite water systems get a tangible asset on their business and real estate, and can enjoy better water quality at a lower cost.

Out of the public’s eye and with OriginClear’s help, a growing number of self-reliant businesses are building Decentralized Water Wealth™ for themselves while also helping their community. They know that environmental, social and governance (ESG) investing guidelines, which represent $22 trillion of assets under management around the world, specifically note the key indicator of how well corporations manage their water.


10,000 Gallon per Day Industrial Membrane Bioreactor Waste Water Treatment Plant designed by Daniel M. Early, PE, using long-lived Structural Reinforced ThermoPlastic (SRTP)

OriginClear is a key enabler of ESG water management for corporations that are increasingly responsible for what was once delegated to central utilities. For example, when a corporation manages its own water, and uses OriginClear’s proprietary hybrid treatment methods, it can significantly reduce both water use and nutrient footprints (carbon, nitrogen, and phosphorus) in one compact package.

These hybrid processes feature advanced blackwater treatment with advanced clean water processing. They can convert toxic nutrients to less harmful compounds, and even capture them for beneficial reuse purposes, as shown in OriginClear’s recent case study.

Revenue Growth through Synergy

Since OriginClear acquired it in 2015, Progressive Water Treatment has generated steady revenues in the range of a million dollars a quarter. It is now the Fabrication and Manufacturing Division for the whole company. The team at Modular Water Systems, headed by Chief Engineer Daniel M. Early, is responsible for overall design and high-level engineering. It relies on the Fabrication and Manufacturing Division to add incremental revenue for its modular product line, without requiring large increases in personnel.

OriginClear believes that these two business units can develop growing revenues through synergy and ultimately help achieve overall profitability. OriginClear also seeks to acquire profitable water companies that can complement the synergy of its existing units and accelerate both revenues and profitability. However, acquisitions are neither guaranteed, nor essential to OriginClear’s continued growth.

 

Leadership

OriginClear’s management team brings strong leadership and a background in managing business operations, sales, technologies, and finance. The team combines idealism with solid commercial skills, achieving a triple bottom line of environmental, social and financial gain.

Riggs Eckelberry – Chairman, CEO and Co-founder
Riggs Eckelberry is a veteran technology manager who led companies to multiple exits during the high-tech boom of the 90s and early 2000s. Eckelberry came to the water industry from a quarter century in high technology, specializing in commercializing breakthrough technologies. During the dotcom boom, he worked on a series of tech successes, such as Quarterdeck’s CleanSweep; security software vendor Panda Software; and the sale of companies to EarthWeb, BeFree, and BellSouth. Just prior to founding what is now OriginClear, he helped drive security software company CyberDefender to an IPO on the Nasdaq as its president and chief operating officer.

Thomas Marchesello – Chief Operating Officer
Thomas Marchesello is a business operations and technology executive with over 20 years’ experience in manufacturing and distribution of products and services. He has 12 years in private equity M&A, doing buyside acquisitions of small to midsize corporations. He has over 10 years advising innovative corporations on ESG strategy and speaks often about industry trends. He began his career in the U.S. Air Force, Space Command Headquarters for environmental sciences. He has held key roles for Fortune 500 companies such as Sony, Thompson Reuters, Morgan Stanley, and Chicago Mercantile Exchange.

Daniel M. Early, PE – Senior Engineer
For the past 25 years, Dan Early has worked as an engineered products development specialist with very strong understanding of the complex and interconnected disciplines, economies, and governmental regulation needed to develop and sustain modern civil infrastructure systems that reflect a balance of environmental stewardship, social expectations, and cultural requirements. Since 2010, Early has specialized in the research, development, and deployment of next generation water infrastructure technologies using heavy plastic manufacturing. His initiatives and innovations anchor Modular Water Systems’ product line.

Marc Stevens – Director of Fabrication and Manufacturing
Marc Stevens brings nearly 40 years of experience to OriginClear’s manufacturing team. His experience in mechanical design, equipment fabrication, installation and a wide range of projects led to his founding what is now OriginClear’s Fabrication and Manufacturing Division. He supervises the design, building and installation of customized, large-scale water treatment systems, including purification technologies for process waters for boilers and cooling towers, drinking water and various industrial waste water applications. Stevens leads the team that also manufactures OriginClear’s standardized Modular Water Systems.

OriginClear (OCLN), closed Friday's trading session at $0.24, up 2.1277%, on 235,220 volume with 35 trades. The average volume for the last 3 months is 39,900 and the stock's 52-week low/high is $0.100000001/$5.80000019.

Recent News

VIVO Cannabis Inc. (TSX.V: VIVO) (OTC: VVCIF)

The QualityStocks Daily Newsletter would like to spotlight VIVO Cannabis Inc. (VVCIF).

VIVO Cannabis (TSX.V: VIVO) (OTCQX: VVCIF), an Ontario-based cannabis company recognized for its premium products and services, today announced its new Cannabis 2.0. products set to come to market in the coming months across Canada.  According to the update, VIVO will focus on the vape, chocolates and concentrates categories leveraging its premium adult-use cannabis brands including Canna Farms(TM) and Fireside(TM). To view the full press release, visit http://cnw.fm/uJTd2.

VIVO Cannabis Inc. (TSX.V: VIVO) (OTC: VVCIF) is a globally licensed, cost efficient producer of premium quality, organic, standardized medicinal cannabis. One of the earliest licensed medical marijuana producers under Canada’s federally-controlled Access to Cannabis for Medical Purposes Regulations (ACMPR), VIVO has five years of operating experience in the burgeoning medical marijuana space through its flagship operation, ABcann Medicinals, Inc. The company recently received its Health Canada license to produce medical cannabis oils and is working toward production of saleable, extracted, finished products that will lead to a final inspection allowing sales of its oils.

“Receipt of the license to produce cannabis oils is a major milestone in our pursuit to provide our medical cannabis patients with additional product formats that can be precisely dosed. The expansion and innovation of our product lines are a top priority for the Company as we continue to serve the needs of our customers, and we anticipate strong demand for our cannabis oil products,” VIVO CEO Barry Fishman said.

VIVO owns and operates a fully functioning 14,500 square foot facility in Napanee, Ontario, which is being doubled in size to produce 1,400 kg of cannabis per year. The company’s expansion plans include adding a seasonal greenhouse and a hybrid, multipurpose facility, capable of producing 31,000 kg of cannabis per year between the two facilities, to be constructed on 65 acres it already owns near the Napanee facility. This additional location is properly zoned with existing infrastructure in place for an eventual 1.2 million square feet of production space.

VIVO has built a reputation over the years for its best-in-class standardized approach to growing cannabis that includes the absence of pesticides and a computer monitored growing technique that provides a consistent, pharmaceutical-grade with high yields. The company’s custom, scalable growing chambers with proprietary lighting can be replicated anywhere in the world, leading to lower production costs. This technique has helped it record a customer retention rate of 94.7 percent alongside 30 percent month-over-month customer growth. When combined with VIVO’s current yield rate, which it has measured at roughly 100 percent greater than the industry average, the company has constructed a strong foundation upon which to build a sizable presence in the global cannabis industry.

This global growth potential is illustrated by VIVO’s partnership with Israel’s Syqe Medical, producer of the world’s first selective-dose pharmaceutical grade medicinal plant inhaler. After visiting VIVO’s production facility, Perry Davidson, founder of Syqe Medical, noted that the company’s production technologies put it “in a class with the best in the world” in its ability to produce standardized pharmaceutical grade cannabis.

VIVO’s recent acquisition of Harvest Medicine Inc. represents further progress toward the company’s goal of becoming a vertically integrated medical cannabis company. Harvest Medicine is one of the fastest growing medical cannabis clinics in Canada – adding over 1,200 new patients monthly from a single location – with an aggressive expansion plan and a patient-focused approach that perfectly aligns with VIVO’s philosophy of quality and innovation.

VIVO’s seasoned management team, board of directors and advisory board features well over a century of combined industry experience. Fishman, who has over 20 years of experience as a business leader, previously served as CEO of both Teva Canada and Taro Canada, as vice president of marketing at Eli Lilly Canada, and as past chair of the Canadian Generic Manufacturers Association. He most recently served as CEO of international specialty pharmaceutical company Merus Labs.

Notably, VIVO also has access to the ‘Father of Cannabis Research’, Raphael Mechoulam, PhD, through its board of advisors. An organic chemist and professor of medicinal chemistry at the Hebrew University of Jerusalem, Mechoulam was the first scientist to isolate both cannabidiol (CBD) and tetrahydrocannabinol (THC). He has received more than 25 prestigious academic awards, including the Rothschild Prize in Chemical Sciences and Physical Sciences in 2012.

With more than 65 acres of growth capacity, a healthy cash balance to fund upcoming construction efforts, steady sales growth, industry-leading yield rates and an established operations team in place, VIVO is well positioned to compete in the rapidly expanding Canadian cannabis industry and beyond.

VIVO Cannabis Inc. (VVCIF), closed Friday's trading session at $0.1622, up 9.5946%, on 81,927 volume with 73 trades. The average volume for the last 3 months is 132,979 and the stock's 52-week low/high is $0.139899998/$0.930000007.

Recent News

VPR Brands, LP (VPRB)

The QualityStocks Daily Newsletter would like to spotlight VPR Brands, LP (VPRB).

VPR Brands, LP (VPRB) was featured today in a publication from CBDWire, examining how, chances are you’ve already heard of cannabidiol (CBD), or if you haven’t, someone next to you has. Despite being barely known just a few years ago, the hemp extract is all the rage these days. Last year, CBD gummy bears were the third most searched for food by Americans, and interest in CBD-infused products is expected to increase with time.

Florida-based VPR Brands, LP (VPRB) is an innovative technology holding company whose assets include patented atomization-related products and technology. VPR Brands' current lineup of products includes accessories and vaporizers for cannabidiol (CBD), cannabis concentrates and extracts. The company is also engaged in product development within the vaping market and partners with top international brands to elevate their products within the vaping industry.

VPR Brands employs a growth strategy centered on high-performance, high-quality products that build exponential brand equity, awareness and loyalty. The company's current product portfolio is comprised of the following:

  • GoldLine combines premium ingredients and extracts coupled with the newest in technology to achieve the ultimate selection of cannabidiol (CBD) and hemp-based products available anywhere. The product range is designed for a wide variety of consumers and features edibles such as gummies and pure honey stix, tinctures, pre-rolled flower, vapable products and creams. For more information please visit www.cbdgoldline.com.
  • HoneyStick is a lifestyle brand that combines the features of high tech, high performance, dependability and affordability when it comes to upper tier vaporizers. HoneyStick was first to market in creating a Sub Ohm vaporizer to the latest Ripper and Plasma GQ. The HoneyStick team works with a vast network of growers, extractors and industry figures to bring the needs of patients and recreational users to life. HoneyStick is sold online and through a diverse network of distributors, e-tailers, dispensaries and smoke shops. For more information about HoneyStick, visit www.vapehoneystick.com.
  • Helium brings the vaping experience to a new level with intense flavors that are steeped to perfection and chilled at 20 degrees below room temperature. Helium's chillers are scientifically proven to preserve flavor, freshness and aroma. Helium is in a 50ml durable and squeezable bottle with drip tip that is functional from the start, engineered to deliver 77 percent VG.
  • Vaporin delivers Sub Ohm series starter kits. Vaporin also provides an eye-catching display case with multi-packs of selected starter kits, coils and premium e-liquids for retail and dispensary operations.
  • Vaporx offers the most current, highest quality products from the best-known brands, including KangerTech, eLeaf, Aspire, Pioneer4You, JoyeTech, Samsung. Vaporx acts as an extension to a client's purchasing department, providing the option to schedule regular product mix refresh for maximum sales.
  • GoldLine Hemp products are developed specifically for the convenience store market segment. GoldLine Hemp-only products are created without CBD, providing an alternative product line for consumers who are not ready to experience CBD products but still want to take advantage of this rapidly expanding class of products. GoldLine Hemp-only edible Hemp Gummies debuted at the National Association of Convenience Stores (NACS) Expo in Las Vegas in October 2018 and are now being distributed nationwide. The U.S. convenience store industry, with more than 154, 000 stores nationwide, serves 160 million customers daily and has sales that are 10.8% of the total U.S. retail and food service sales. Visit www.goldlinehemp.com for more information about GoldLine Hemp-only products.
  • Vapor Store Direct in Fort Lauderdale, Florida, is one of the largest vaporizer and e-liquid wholesalers in the United States. Vapor Store Direct stocks internationally elite brands, vaporizers, tanks/atomizers, coils, e-liquid, e-cigarettes, batteries, glass and accessories.

Management Team

CEO Kevin Frija is a veteran entrepreneur with nearly 30 years of experience in sourcing, manufacturing, supply chain management, marketing, advertising and brand licensing. In 2009, Frija became the president and chief executive officer of Vapor Corp., one of the first U.S. importers and publicly traded electronic cigarette companies. In 2016, Frija purchased the brands and wholesale business assets from Vapor Corp., which is now owned by VPR Brands. Under his leadership, VPR Brands is pivoting toward cannabis products which is increasing sales and profit margins.

Dan Hoff, chief operating officer, has worked in the vaporizer and e-cigarette industry, serving in various positions at Vapor Corp., including overseeing the financial management, accounting functions, supply chain management, product design and development, and key vendor relations. He has played a pivotal role in building and expanding the cannabis-based products division at VPR Brands, which includes a turnkey OEM vapor solutions program available to farmers, cultivators and extractors. Hoff received his bachelor's degree from the University of Miami School of Business.

VPR Brands, LP (VPRB), closed Friday's trading session at $0.039, up 25.8065%, on 9,000 volume with 3 trades. The average volume for the last 3 months is 59,973 and the stock's 52-week low/high is $0.030999999/$0.119000002.

Recent News

Sugarmade, Inc. (SGMD)

The QualityStocks Daily Newsletter would like to spotlight Sugarmade, Inc. (SGMD).

Sugarmade (OTCQB: SGMD), a major supplier to the hydroponic cultivation and hemp sectors, today announced its entry into the hemp extraction and laboratory equipment marketplace, one of the fastest-growing areas of the overall hemp industry. In addition, the company announced that it has begun shipments of equipment to be installed in one of the largest planned facilities in the eastern portion of the United States. To view the full press release, visit http://cnw.fm/V0qqI.

Sugarmade, Inc. (SGMD), one of the largest publicly traded hydroponics supply companies moving into the industrial hemp space, is a product and brand marketing company investing in products and brands with disruptive potential. Sugarmade’s brands include: ZenHydro.com; CarryOutSupplies.com; and BudLife. Headquartered in Monrovia, California, a city within Los Angeles county, Sugarmade has various business operations in diverse marketplaces including packaging and paper goods for various industries, agricultural supplies.

Sugarmade has expanded into the European hydroponics supply market with a growing base of orders taken through Amazon UK. Over the past few financial quarters, Sugarmade has seen revenue growth patterns expand geographically. As recently as mid-2017, the majority of hydroponic-related revenue growth was seen from California and other West Coast marketplaces, however growth is becoming more geographically dispersed among U.S. states where legalization has eased restriction. This movement into the United Kingdom further expands the base of geographic growth areas for Sugarmade.

Sugarmade recently launched a new corporate initiative in the booming industrial hemp and CBD, committing up to $1 million in capital over the next 12 months to invest in Hempistry, Inc., a privately held Nevada corporation. Hempistry has begun planting an ultra-high cannabidiol (CBD) industrial hemp strain on a land option it holds on 23,000 acres of prime Kentucky farmland. The strain of industrial hemp being grown by Hempistry is ultra-rich in CBD but contains less than 0.3 percent of THC, the psychoactive ingredient found in cannabis. The U.S. hemp industry is expected to produce well over $1 billion in revenues in 2018, with a compound annual growth rate of 14 percent through 2022, according to the Hemp Business Journal.

Demand for industrial hemp and products derived from hemp is soaring, with no let-up in sight, which the company sees as a “tremendous opportunity to become a supplier to this fast-growing sector,” said Chairman and CEO Jimmy Chan, who is also an advisor and minority shareholder of Hempistry.

Sugarmade’s investment into the market for high-CBD hemp is expected to be highly accretive for common shareholders in two ways. First, Sugarmade’s investment will be in the form of common shares in Hempistry allowing Sugarmade common shareholders to possibly benefit from any future initial public offering of Hempistry. Second, Sugarmade is expected to sign a supply agreement with Hempistry for cultivation supplies, which would be additive to corporate revenues.

Sugarmade has also completed a master market agreement with industry leader BizRight Hydroponics, Inc., a leading marketer and manufacturer of cannabis and hydroponic growth supplies, which offers a range of hydroponics-related products including: HPS grow lights, electronic ballasts, HPS bulbs, nutrient mixes, environmental control products, pH measurement and calibration solutions and storage products. BizRight operates the ZenHydro.com website and other e-commerce properties and sells various products to distributors and retailers. BizRight is expected to produce in excess of $30 million in revenues during 2017, with substantial growth expected for 2018.

Sugarmade division CarryOutSupplies.com, the leader in paper and plastic take-out supplies, serves nationwide customers by offering a wide array of high quality products that are cost-efficient, custom-made and delivered on time. This business unit currently serves 2,000 quick service restaurants, garnering from 30-40 percent of the market share. Sugarmade plans to expand operations via the addition of market share and the introduction of new product offerings.

Management

CEO Jimmy Chan is an experienced business executive instrumental in growing multiple business operations with a strong expertise in international trade and banking, and international manufacturing and importation. He is also the founder of CarryOutSupplies.com, a company that revolutionized the custom-printed paper supplies subsector of the quick service restaurant industry, which merged with Sugarmade in 2014.

Arman Tabatabaei serves as operations consultant, providing high-level, day-to-day strategic guidance and tactical operational supervision for all aspects of the corporation’s business. He is an expert at data collection and analysis relative to resource management, risk forecasting and profit and loss management.

Sugarmade specializes in growing and acquiring innovative brands to maximize value for company employees, shareholders and other stakeholders. Sugarmade believes its future is very bright as the company expands operations within the cultivation sector and rapidly increases its revenue base. 6

Sugarmade, Inc. (SGMD), closed Friday's trading session at $0.01315, up 19.5455%, on 13,630,092 volume with 465 trades. The average volume for the last 3 months is 6,000,075 and the stock's 52-week low/high is $0.0073/$0.125.

Recent News

SinglePoint, Inc. (SING)

The QualityStocks Daily Newsletter would like to spotlight SinglePoint, Inc. (SING).

Technology and investment company SinglePoint (OTCQB: SING) was featured on this week’s episode of MoneyTV with Donald Baillargeon. The internationally syndicated program covers money-focused topics, featuring various companies and in-depth interviews with CEOs and executives that offer insights into operations and future outlooks. To view the full press release, visit http://cnw.fm/E73kD. Also today, the company was highlighted in a publication from HempWireNews, examining how hemp stakeholders such as lawmakers and trade organizations, as well as the advocates, are continuing to lobby on matters connected to the interim federal government funding proposal irrespective of the absence of a language creating a pathway for hemp or CBD products.

SinglePoint, Inc. (SING) is a diversified holding company with operations in multiple industries and verticals including two high-performing market sectors: legal cannabis and cryptocurrencies. SinglePoint has grown from a full-service mobile technology provider to a recognizable brand with a diverse portfolio of undervalued subsidiaries with multiple revenue streams.

SinglePoint is researching opportunities where it can be an active participant by influencing the strategy and direction of high-potential companies whose verified assets offer attractive possibilities for shareholders. The company is guided by a visionary leadership team with extensive experience in technology, engineering, marketing and raising capital.

SinglePoint is bullish on the cannabis industry, bitcoin and blockchain technologies, which is evident in its recent acquisitions and joint-venture announcements. Recent SinglePoint key highlights include:

  • A joint venture with Smart Cannabis Corporation (OTC: SCNA) to license and market Smart Cannabis’ SMART APP. SMART APP enables cannabis growers to measure all aspects of cultivation, from soil nutrient levels to watering cycles and carbon dioxide content in the air. SMART APP will integrate SinglePoint’s bitcoin payment solution to enable growers to process safer and more secure transactions.
  • A joint venture with Global Payout (OTC: GOHE) will build on existing financial technology solutions developed by SinglePoint and Global Payout’s subsidiary MoneyTrac Technology, Inc., to fully optimize the delivery of mobile payment applications for domestic and international organizations.
  • A joint venture with AppSwarm (OTC: SWRM) to start development on a proprietary delivery application that will enable licensed cannabis delivery services and licensed dispensaries to safely make in-home cannabis deliveries.
  • Signed original “Shark Tank” member Kevin Harrington as company spokesman for an innovative, compatible virtual wallet to store any type of cryptocurrency. Harrington recently finished shooting a new national ad campaign featuring SinglePoint and the virtual wallet’s secure method of storing cryptocurrencies.
  • Entered into a letter of intent to acquire 100 percent of Bitcoin Beyond, a premier platform that enables merchants to accept bitcoin payments using existing web-enabled point-of-sale devices.
  • Through SING subsidiary, SingleSeed, the company will soon offer a proprietary cryptocurrency solution that links both cannabis merchants and consumers who seek to take advantage of bitcoin-powered transactions using debit and credit cards. In addition to making bitcoin-backed card purchases possible, the solution enables cannabis dispensaries to digitally track and manage their product inventories, performing tasks like uploading product data, photos and descriptions. The system deducts items automatically from a dispensary’s product listings when a purchase is made. While this fully KYC-AML compliant point-of-sale platform can be utilized for any other retail setting, it will fill a critical need in the underbanked cannabis industry as it continues to seek non-cash payment solutions outside of traditional banking circles.

SinglePoint CEO and founder Greg Lambrecht leads the company in its mission to capture opportunities through an aggressive expansion strategy across a broad range of assets. Lambrecht oversees all company operations including investor relations, leadership of the board of directors, and daily business activities. As the founder of PCI, a leading consumer product distribution company, Lambrecht negotiated agreements with the nation’s largest retail outlets and led PCI through a NASDAQ listed IPO, raising $10 million.

Eric Lofdahl, SinglePoint’s chief technology officer, has more than 20 years of experience in the technology sector including positions in software development, program management, complex system integration and engineering process definition. Prior to SinglePoint, Lofdahl worked at the Boeing Company where he led a team that successfully developed advanced wireless and satellite data products based on commercial technology for the U.S. Air Force.

SinglePoint President Wil Ralston is well known for his successful track record of building and maintaining great relationships with clients. Ralston graduated cum laude from the WP Carey School of Business at Arizona State University with a degree in Global Agribusiness and a specialization in Professional Golf Management. He is currently recognized by the Professional Golfers Association of America (PGA) as a Class A Professional.

SinglePoint, Inc. (SING), closed Friday's trading session at $0.0091, up 1.1111%, on 3,038,300 volume with 85 trades. The average volume for the last 3 months is 2,808,645 and the stock's 52-week low/high is $0.008/$0.028799999.

Recent News

MCTC Holdings Inc. (OTC: MCTC)

The QualityStocks Daily Newsletter would like to spotlight MCTC Holdings Inc. (MCTC).

MCTC Holdings Inc. (OTC: MCTC) was featured today in a publication from HempWireNews, examining how, on Tuesday, the House of Representatives voted on the interim funding bill, and the Senate is scheduled to vote for the measure on Thursday. President Trump is supposed to sign the proposal before Friday to avoid the government being partially shutdown at the beginning of 2020.

MCTC Holdings Inc. (OTC: MCTC) is an innovator in the field of cannabinoid nanoparticles and infusion technologies with several important cannabinoid patents filed and an active research and development program underway. The company was reorganized during June of 2019 and announced its intent to enter the cannabis sector and change its corporate identity to Cannabis Global Inc. The company is headquartered in Los Angeles, California.

With the hemp and cannabis industries rapidly expanding in terms of market size, acceptance and number of market participants, MCTC plans to concentrate its efforts on the middle portions of the hemp and cannabis value chain. The company is actively pursuing R&D programs and productization of advanced cannabinoid delivery systems, based on solid polymeric nanoparticles and fibers. These technologies hold the promise to revolutionize the science of cannabinoid bio-enhancement for use in foods, beverages, consumer products and in transdermal applications. Because of nanoparticles’ ability to be quickly absorbed into the bloodstream, nanotechnology has been utilized in the food and drug industry for some time and has the potential for tremendous growth in the cannabis industry (http://nnw.fm/v6RQ6).

Cutting-Edge Technology

MCTC is at the cutting-edge of the cannabis industry’s trends with its emphasis on polymeric nanotechnology. This is not to be confused with the more basic oil-in-water nano-emulsions currently marketed to the food and beverage industry. The company’s polymer-based particles offer significant loading of active ingredients and unmatched flexibility and customization, allowing for myriad combinations of cannabinoids with unique performance characteristics. MCTC believes polymeric nanotechnology particles will be a critical technology area for the cannabinoid formulation marketplace.

The company continues to build its R&D program, specifically researching the development of improving methods to make cannabinoids available to living systems. Instrumental in the research program is the development of novel polymeric nanoparticles and nanofibers. These have the potential to elevate the potential of cannabinoid products in the following ways (http://nnw.fm/cK3Bl):

  • Significantly improving bioavailability
  • Allowing for ultra-high loading rates
  • Enhancing customization of cannabinoid combinations
  • Improved dosing precision
  • Providing more control in release parameters

MCTC leadership understands the importance of developing intellectual property (IP) in the ever-evolving cannabis industry. A recent Forbes article described IP as “critical for creating true differentiation between companies and their product and service offerings” (http://nnw.fm/57Fjh). Recognizing the importance of IP, MCTC has been consistent in its application for patents to protect its innovative nanotechnology applications.

Patents

MCTC has now filed four patents on its cannabinoid delivery technology systems:

  • The company first collaborated with Cannabis Nanosciences Inc. on technologies. This became the basis for its first patent filing on an innovative edible dissolvable film for cannabinoid ingestion.
  • Its second patent filing for cannabinoid nanoparticles combined TPGS, a water-soluble form of vitamin E.
  • Its third patent filing involved a unique 4th dimension, 3D printed cannabinoid delivery system for beverages.
  • Its fourth patent, considered its most significant, broadly covers many aspects of nanoparticles and nano fibers comprising one or more cannabinoids disposed at least partially within a water-soluble medium.

Collaborations

MCTC collaborated with Marijuana Company Inc. (OTCQB: MCOA) subsidiary hempSmart Inc., under a hemp extract and CBD product supply agreement wherein hempSmart will utilize its extensive network of marketing partners to market MCTC’s powered drink mixes and other CBD edibles online. These products are designed for the dry beverage and edibles sector and will be supplied by MCTC. They incorporate the company’s patent-pending cannabinoid infusion technologies and will be trademarked as Hemp You Can Feel (TM) and Gummies You Can Feel (TM).

Leadership

MCTC CEO and chairman Arman Tabatabaei boasts 15 years of management and operations experience and is considered an expert at data collection and analysis relative to resource management, risk forecasting, and profit and loss management. He has acted as a consultant with Cannabis Strategic Ventures (OTCQB: NUGS) and played an instrumental role in improving operations at Sugarmade Inc. (OTCQB: SGMD) relative to the company’s hydroponic growth supplies initiatives.

MCTC founder and director Robert Hymers also brings a seasoned perspective, having had significant experiences in the cannabis industry and as a financial executive and consultant. He is the managing partner of Pinnacle Tax Services in Los Angeles and was previously CFO and director of Marijuana Company of America Inc. (OTC: MCOA). He is currently a member of the Strategic Advisory Board at Massroots Inc. and acts as a consultant to both Cannabis Strategic Ventures Inc. and Sugarmade Inc. Hymers’ background in tax accounting, auditing, SEC reporting, mergers and acquisitions, and corporate finance has immense value in his current position at MCTC Holdings.

MCTC Holdings Inc. (MCTC), closed Friday's trading session at $0.35, even for the day, on 10 volume with 1 trade. The average volume for the last 3 months is 10,858 and the stock's 52-week low/high is $0.075000002/$3.00.

Recent News

ChineseInvestors.com (CIIX)

The QualityStocks Daily Newsletter would like to spotlight ChineseInvestors.com (CIIX).

ChineseInvestors.com’s (OTCQB: CIIX)subsidiary CBD Biotech Co. Ltd. CEO Summer Yun was recently featured in a “Wall Street Journal” video titled “Why China Is Betting Big on CBD” (http://cnw.fm/QW9t8). To view the full article, visit http://cnw.fm/6ZpoD. Also today, the company was featured in the 420 with CNW by CannabisNewsWire. Marijuana destinations are a trend that is accelerating in the travel industry across the globe. This is because marijuana fans are always on the lookout for the next adventure and they love trying out new things.

Founded in 1999, ChineseInvestors.com (CIIX) has become a leading financial information website for Chinese-speaking investors in the United States and China. Recognizing unprecedented opportunities in the U.S. cannabis industry, CIIX is also laying the groundwork to capitalize on growing demand for cannabidiol (CBD)-based nutrition and health products.

Through its primary website, www.ChineseInvestors.com, CIIX offers a variety of investor education products and services, including real-time market commentary, analysis and educational related services in Chinese language character sets; consultative services to smaller private companies considering becoming a public company; and advertising and public relations related support services.

At the center of this initiative is the ChineseInvestors Method, a unique integration of a disciplined investing process, web-based tools, personalized instructions and support. Using this strategy, CIIX provides reliable market information to help investors make informed investment decisions and meet their individualized financial goals.

CIIX is also leveraging its financial expertise to enter into the burgeoning CBD industry, which within a few years has grown from a relatively invisible sector to a billowing market expected to reach $2.1 billion in consumer sales by 2020.

The increasing demand for CBD-based products is a catalyst for innovative business endeavors. To this accord, CIIX has established a three-year development plan to capitalize on the convergence of CBD and the nutrition and health products market in mainland China, where the benefits of CBD oil have not been widely recognized.

Under a wholesale agreement with a reputable CBD health brand, CIIX is launching the world’s first online CBD health products store published in the Chinese language. The site, www.ChineseCBDoil.com, caters to a growing number of Chinese people awakening to the numerous health benefits of CBD oil for treatment of a variety of conditions such as anxiety, stress, poor sleep, Alzheimer’s disease, and more. CIIX expects to launch this website at the end of January 2017, and plans to sell CBD-infused products via online and in-store.

In conjunction, CIIX’s cannabis-focused “Yelp”-style mobile app is in development as a platform for Chinese people to review and discuss various cannabis products. The app will be the first marijuana social media mobile app designed for Chinese-speaking customers worldwide.

ChineseInvestors.com (CIIX), closed Friday's trading session at $0.19, even for the day, on 16,604 volume with 14 trades. The average volume for the last 3 months is 48,357 and the stock's 52-week low/high is $0.165000006/$0.560000002.

Recent News

HTC Extraction Systems (TSX.V: HTC) (OTCQB: HTPRF)

The QualityStocks Daily Newsletter would like to spotlight HTC Extraction Systems (TSX.V: HTC) (OTCQB: HTPRF).

HTC Extraction Systems (TSX.V: HTC), a hemp-biomass processing entity, recently announced financial results for third quarter that showed a year-over-year (“YoY”) revenue increase of over 2.5 times. An article discussing the company reads, “HTC’s revenues grew from $1.3 million at the September close of the quarter in 2018 to $3.3 million at the quarter’s end this year, according to the report (http://cnw.fm/5bMiP). To view the full article, visit http://cnw.fm/15dAA.

HTC Extraction Systems (TSX.V: HTC) (OTCQB: HTPRF) has developed and optimized proprietary technologies designed for biomass extraction, distillation and purification of ethanol and ethanol-based solvents used for the hemp biomass and cannabidiol (“CBD”) industry, as well as gas and liquid extraction. HTC’s extraction & purification systems are engineered to large-scale to reduce capital and operating costs while delivering superior performance measured by reduced energy usage, lowered emissions and improved quality of the product produced.

Advanced Extraction Technologies

For more than 14 years, HTC has developed and optimized proprietary technology and purification systems used for biomass, gas and liquid extraction. These technologies include:

  • LCDesign® – Low-cost design for modular gas, liquid and biomass extraction systems optimizes plant design, thus reducing capital and operating costs.
  • PDOEngine™ – Software-based design algorithms accurately model and simulate gas, liquid and biomass extraction processing.
  • Delta Solvents™ – Custom-designed, ethanol-based solvent mixtures and additives that optimize production and reduce costs. Technology development is being conducted at HTC’s sponsored research facilities at the University of Calgary.

Delta Purification® Technology

HTC’s patented Delta Purification® technology will purify, recycle and reuse the extraction ethanol used in the CBD extraction process while managing and reducing any CBD waste losses through the re-extraction of all wastes collected from the purified ethanol. Current and new technologies include:

  • Delta CBD Reclaiming System: Reclaiming and purifying ethanol for use in CBD extraction from biomass. Reduces required heat to prevent damage of the chemical attributes of the CBD molecule, allowing extracted CBD to meet food-grade targets for human consumption.
  • Delta Solvent Reclaiming System: Reclaiming and purifying ethanol-based solvents, such as single, mixed and formulated amines, for use in natural gas processing and post-combustion CO2 capturing processes.
  • Delta Glycol Reclaiming System: Reclaiming and purifying glycols, such as mono-ethylene glycol and tri-ethylene glycol for use in natural gas dehydration processes.

Hemp Biomass and Tolling Contracts

HTC has entered into a hemp biomass tolling agreement for the 2019 crop year involving a supply of hemp biomass from a hemp grower in Saskatchewan, Canada. The hemp grower utilizes five varieties of Health Canada-approved cultivars as the genetic foundation. HTC will process and extract CBD FSO distillate from the hemp biomass. As a tolling fee payment, HTC will receive a percentage of the extracted CBD FSO distillate for its processing, extraction, purification and distillation services.

Additional hemp biomass tolling contracts with producers and hemp biomass providers are being negotiated in the U.S. for the 2020 hemp crop growing year. HTC will provide “local-to-grower” drying-to-biomass storage capability and transportation of dried biomass to an HTC, location to be determined, future US based, extraction facility. HTC is also in negotiation with a 60,000-acre, recognized Canadian farm leader, who is a significant hemp biomass producer, for a similar hemp biomass tolling contract.

re3™ Technology

Large users of ethanol and solvents for plant oil extraction demand reduced capital and operating costs. HTC’s re3™ (reclaim, recycle, reuse) technology can save up to 30% of the required fluid costs. The increasing cost of new extraction ethanol, combined with the cost of used ethanol disposal, creates a unique opportunity whereby the re3™ technology will create cost savings, while meeting environmental responsibilities.

The growth of ethanol and CO2 used in CBD production has created a new demand for reliable commercial scale ethanol reclaimer systems. The Delta Purification® ethanol system meets this new demand.

Sales and Offtake Agreements

HTC intends to leverage its relationship with its related entity, Purely Canada Foods™, to provide sales and distribution for its Ingredient CBD market under the brand of Purely Canada Hemp™, Purely Canada CBD™, Purely Canada Cannabinoids™. Purely Canada Hemp™ will develop risk managed multi-year ingredient supply contracts with its existing and new Global Food, Beverage and Animal Food Industry Customers.

Project Construction

HTC has focused the Canadian implementation of its BOOM (build, own, operate and maintain) extraction tolling strategy on a location near Regina, Saskatchewan. HTC is currently constructing a 19,000-square-foot GMP Euro compliant extraction tolling facility on six acres of land that will include biomass processing, extraction, implementation of DeltaSolv™ technologies and Delta Purification® systems, distillate and refining equipment, laboratory quality control and testing operations, and on-site office and admin facilities.

Leadership

Chairman, CEO and Director Lionel Kambeitz is a recognized professional in business development and international business relations. He has played a founding role in many other Canadian and U.S.-based companies. Kambeitz has executive experience in a variety of industries including energy, agriculture, food production engineering, and manufacturing.

Jeff Allison, Senior Vice President, Chief Financial Officer and Director, has over 20 years of experience in corporate finance and business development. Prior to joining HTC in 2005, Allison as Vice President assisted with the founding and setup of CUCORP Financial Services in Saskatchewan.

HTC Extraction Systems (OTCQB: HTPRF), closed Friday's trading session at $0.1537, even for the day, on 250 volume. The average volume for the last 3 months is 4,470 and the stock's 52-week low/high is $0.07/$0.920000016.

Recent News

Sharing Services Global Corporation (SHRG)

The QualityStocks Daily Newsletter would like to spotlight Sharing Services Global Corporation (SHRG).

Sharing Services Global’s (OTCQB: SHRG) Elepreneurs subsidiary is utilizing a platform from Verb Technology in the United States to continue its substantial sales growth in the direct-selling market and plans to launch the platform in Canada soon (http://nnw.fm/cB01C). To view the full article, visit http://nnw.fm/IRt7h. Also today, NetworkNewsWire released a report on the company detailing how SHRG has had an exciting year and is looking to the New Year with strategic plans for expansion. A record first quarter, a new video-based CRM and sales-enablement platform, continued organic growth and an influx of entrepreneurs mark company milestones and position SHRG perfectly to advance into 2020.

Sharing Services Global Corporation (SHRG), headquartered in Plano, Texas, is a diversified holdings company focused on reshaping how entrepreneurs succeed today. Sharing Services Inc. owns, operates or controls an interest in a variety of companies specializing in the direct selling industry that either sell products to the consumer directly through independent representatives or offer services that range from health and wellness, energy, technology, insurance services, training, media and travel benefits. SHRG has created the “Blue Ocean Strategy,” which melds three keys together to implement the company’s vision. These keys include elevating home-based entrepreneurs, known as “Elepreneurs,” utilizing the direct selling channel to generate 100 percent organic growth.

Sharing Services Inc. subsidiaries include:

  • A growing international network of home-based entrepreneurs, called “Elepreneurs”
  • Growing selection of health and wellness products dedicated to elevating the well-being of all people
  • Insurance from auto, home and life to health benefit discounts and health insurance that help families elevate their options
  • Wholesale travel and payment programs with travel concierges that empower more families to go on vacation
  • Live seminars and training events – from Vacationars™ to EduTainment – that elevate the skills and knowledge of entrepreneurs around the world
  • Unique compensation and reward programs crafted to help entrepreneurs elevate their health, wealth and happiness

Sharing Services recently expanded its corporate footprint by moving to a 10,000 square foot facility in Plano, Texas, that offers room to expand as the company grows and its subsidiaries flourish. The larger corporate locale provides space for a growing customer service department, product fulfillment, opportunity and training rooms, as well as a video production suite.

“The opportunity to expand to the rest of this new building over the course of the next six to 12 months ensures we won’t have to move again anytime soon,” Sharing Services Inc. Chairman Robert Oblon said. “We are on track for very significant growth here in the U.S., as well as upcoming international expansion, so this move is in preparation for what’s in front of us.”

The company recently signed a joint venture agreement with Health Wealth & Happiness Limited (“HWH”) to expand its “Elepreneurs” brand and market its products throughout Asia. The newly formed company will be named “Elepreneurs Asia Limited” and will have marketing and sales rights to China, Hong Kong, Macau, South Korea, Japan, Taiwan, Cambodia, Indonesia, Laos, Malaysia, the Philippines, Singapore, Thailand, Vietnam and Papua, New Guinea. A soft launch of the Elepreneur program is scheduled sometime later in 2018 with HWH CEP Fai Chan and his team leading the effort. Formed in Hong Kong, Health Wealth & Happiness Limited is dedicated to working with visionary partners like Sharing Services Inc. to deliver the best products and services to improve the well-being of consumers.

Nearly 1,000 people attended Sharing Services Global Corporation ’s first “Elepreneur Happiness Convention,” held March 2-3, 2018, in Dallas, Texas. Attendees arrived from several countries including the U.S., Canada, Mexico, Singapore and Hong Kong. Keynote speakers included several internationally known motivational leaders – Shawn Achor, Sandra Yancey, John Fleming and Les Brown – who provided exceptional material and inspirational discussion points.

“The enthusiasm of our attendees and the early success that we are experiencing is incredible considering our growth has been 100 percent organic, with almost no marketing from the company,” Oblon said. “I’m speechless by the dedication of our Elepreneur leaders and their entire teams, as they share our incredible line of products that have helped so many people.”

Sharing Services and its management team plan to travel the U.S. to hold several mini conferences to expand on the messages presented at its Happiness Convention that focus on helping people become “healthier, happier and wealthier.” Details of the company’s aggressive global expansion initiatives are soon to be announced, Oblon said.

The law firm of Gardere Wynne Sewell LLP has been retained as outside corporate counsel for all general business matters. The Dallas-based law firm will represent Sharing Services Global Corporation , and its subsidiaries as the company utilizes the direct selling channel for a significant component of its overall growth strategy.

John “JT” Thatchwas appointed president and chief executive officer of Sharing Services Global Corporation , at a March 1, 2018, annual shareholder meeting. Thatch has successfully started, owned and operated several sized businesses in various industries. His experience with corporate growth, acquisitions, financing and negotiation in fast-paced and flexible environments will significantly assist Sharing Services Inc. as the company aims to expand and increase revenues.

Sharing Services Global Corporation (SHRG), closed Friday's trading session at $0.10, even for the day, on 16,000 volume with 5 trades. The average volume for the last 3 months is 30,194 and the stock's 52-week low/high is $0.065800003/$0.3944.

Recent News

Organigram Holdings Inc. (TSX: OGI) (NASDAQ: OGI)

The QualityStocks Daily Newsletter would like to spotlight Organigram Holdings Inc. (OGI).

Organigram Holdings Inc. (TSX: OGI) (NASDAQ: OGI) was featured today in a publication from MarijuanaStocks.com, examining how, in the past six months, negative news has become the norm talking about marijuana stocks. While this may be the present state of the industry, it seems as though there are some pot stocks that are definitely worth watching. These few companies are making big moves that should help them move into the future of the industry. With all eyes set on the next few years, innovation is leading the charge right now.

Organigram Holdings Inc. (TSX: OGI) (NASDAQ: OGI) is the parent company of Organigram Inc., a leading Canadian licensed producer (“LP”) of high-quality cannabis and extract-based products. Founded in 2013, Organigram is focused on producing high quality, indoor-grown cannabis for patients and adult recreational consumers in Canada, as well as developing international business partnerships to expand the Company’s global footprint. 

The Company has distribution arrangements in all 10 provinces1. Organigram delivers industry-leading yields and maximizes quality cannabis production at the lowest cultivation cost per gram among publicly reporting Canadian LPs.

Financial Results

In Q2 2019, the Company reported record net revenue of C$26.9 million, cash cost of cultivation of C$0.65 per gram, industry leading gross margin of C$16 million or 60% and adjusted EBITDA of C$13.3 million or margin of 49%, positive for the third consecutive quarter.

Significant Expansion Plans with Streamlined Licensing Process

Located in Moncton, New Brunswick, Organigram’s production facility and research & development program includes a state of the art, indoor 3-tier cultivation system which maximizes facility square footage. Its Phase 4 expansion project is expected to be completed by the end of 2019 for increased target production capacity of 113,000 kg/year (249,000 lbs)2. As the Company expands its cultivation and processing capacities, Organigram is able to file amendments to the existing facility and each new production area is largely a replica of previously licensed areas, which results in a relatively streamlined and predictable licensing process with Health Canada.

In addition to increased production capacity from Phase 4, Organigram’s Phase 5 expansion includes plans for additional extraction capacity and its own edibles facility. Construction is expected to be substantially completed in October 2019.

Proprietary Technology

The Company’s indoor facility allows for control of all critical facets of the lighting and environmental elements to drive maximum quality and yield in the plants. The Company’s in-house proprietary information technology system, called OrganiGrow, tracks grow cycles, environmental conditions and other factors to optimize cultivation.

Numerous design and automation improvements include automated potting, pre-roll and packaging machines, and larger propagation rooms with advanced environmental systems.

Well Positioned for Canada’s Legalization of Edibles and Other Derivatives Products

Through its facility expansions, partnerships and research and development, the Company is well-positioned to capture further growth from the legalization of edibles and derivative products expected in October 2019. Its initial product focus is on vaporizable products and edibles.

Organigram’s development of a shelf-stable, thermally stable, water-soluble and tasteless cannabinoid nano-emulsion formulation may provide for an initial onset of effect within 10 to 15 minutes in a beverage. Non-cannabis formulations with a similar molecule size are water-soluble in humans (i.e., absorbed through the bloodstream rather than requiring first-pass liver metabolism, which results in longer onset and duration uncertainty). The Company expects to receive research and development licensing in the near term, at which point testing will be conducted to confirm the onset and duration.

Organigram has entered into an exclusive consulting agreement with The Green Solution (TGS), a proven market leader based in Denver, Colorado for the development of commercial scale extraction and derivative product development in Canada. Organigram’s partnership with Canada’s Smartest Kitchen, a leader in food product development, will expand the Company’s edibles R&D program.

The Company recently announced a C$15 million investment commitment in a high-speed, high-capacity, fully automated production line with a capacity of 4 million kilograms of exceptional chocolate cannabis edibles per year.

Organigram also has a multiyear extraction contract with Valens GroWorks Corp. to produce extract concentrate for oils and other derivative products.

Disruptive Technology

Through its partnership with Hyasynth Biologicals Inc., a biotech company and leader in the field of cannabinoid science and biosynthesis, Organigram has invested in a potentially disruptive technology that uses patented yeast strains and enzymes to naturally produce cannabinoids without growing the cannabis plant. This process has the potential to create a global supply of pure cannabinoids at a fraction of the cost of traditional cultivation. Organigram views this investment as providing early access to what it expects to be the future of cannabinoid production – cost-effectiveness, purity and scalability.

International

Organigram believes there will be increasing demand for CBD in Canada and beyond. As such, the Company has invested in Alpha-Cannabis Germany (ACG) and expects to provide ACG with flower for conversion into extracts. ACG is a medical cannabis provider serving the largest legalized medical market in Europe. The Company anticipates entering into an agreement with ACB to purchase pure synthetic CBD isolate in the future.

Organigram is also invested in Eviana Health Corp. (CSE: EHC), a Serbian-based company with hemp farming and processing assets.

Experienced Executive Team

  • CEO Gregory Engel has 30 years of national and international experience in pharmaceuticals, biotechnology, cannabis, and consumer packaged goods (CPG), and most recently served as CEO of Tilray Inc. where he was instrumental in the company becoming the first Canadian exporter of medical cannabis, as well as establishing several trailblazing industry standards
  • Jeff Purcell, Senior Vice President of operations, has 25 years of experience in operations for companies such as Ganong Chocolates and McCain Foods
  • Tim Emberg, Senior Vice President of Sales and Commercial operations, has 20 years of experience in pharmaceutical sales and marketing in the OTC and CPG industries
  • Paolo DeLuca, Chief Financial Officer, has 20 years of diversified financial business experience including with West Face Capital and TD Securities
  • Ray Gracewood, Senior Vice President, Marketing & Communications, has 15 years of experience in the marketing space and was senior Director of Dales and Marketing for Moosehead Breweries Ltd.

This profile contains certain non-IFRS performance measures including cash and all-in cost of cultivation per gram, net revenue, adjusted EBITDA, and adjusted gross margin which are not calculated in accordance with IFRS and may not be comparable to similar data presented by other companies. Please see the company’s Q2 2019 MD&A.

1 Subject to final regulatory approval from Quebec
2 Several factors can cause actual capacity and costs to differ from estimates. See “Risks and Uncertainties” in the Company’s Q2 2019 MD&A and “Risk Factors” in the latest Annual Information Form.

Organigram Holdings Inc. (NASDAQ: OGI), closed Friday's trading session at $2.38, off by 2.459%, on 1,977,592 volume with 5,632 trades. The average volume for the last 3 months is 2,581,893 and the stock's 52-week low/high is $2.00/$8.43999958.

Recent News

Lexaria Bioscience Corp. (CSE: LXX) (OTC: LXRP)

The QualityStocks Daily Newsletter would like to spotlight Lexaria Bioscience Corp. (LXRP).

Lexaria Bioscience (CSE: LXX) (OTCQX: LXRP), a global innovator in drug-delivery platforms, recently announced further advances in its proprietary, oral, drug-delivery platform: DehydraTECH(TM). To view the full article, visit http://cnw.fm/vOF1Y.

Lexaria Bioscience Corp. (CSE: LXX) (OTC: LXRP) has developed and out-licenses its proprietary DehydraTECH™ technology for improved taste, rapidity and delivery of bioactive compounds, including nicotine and cannabinoids. To achieve higher absorption rates and fast onset, consumers traditionally defaulted to smoking. Lexaria provides a superior administration method by delivering these substances through a patented process within edible food products, thus eliminating all the harmful health consequences of smoking.

Lexaria’s technology is unique in that it takes advantage of GRAS (Generally Recognized As Safe) food ingredients processed with its patented DehydraTECH technology to improve taste, remove odor and decrease the time to onset of bitter-tasting drugs. Lexaria is primarily a B2B enterprise and has existing cannabinoid licensing agreements with companies in Canada and the United States. Lexaria has also developed its own hemp-oil brands partly for demonstration purposes, utilizing its patented technology to infuse hemp oil ingredients within popular foods such as coffee, tea and supplements. These brands include ViPova™, TurboCBD™ and ChargD+™.

Virtually unique across both the hemp and the cannabis industries, Lexaria has successfully entered into a R&D and product development partnership with one of the largest cigarette companies in the world for oral forms of nicotine delivery. Only a small handful of hemp or cannabis-related companies have achieved formal relationships with Fortune 500 industry leaders, demonstrating the wide applicability of Lexaria’s technology.

In June 2019, building on its original 2015 independent, third-party laboratory in vitro lab experiments, which confirmed the absorption levels of cannabidiol (“CBD”) into human intestinal cells rose by 499% through the utilization of the DehydraTECH technology, Lexaria completed a series of animal studies using an enhanced formulation of its DehydraTECH technology. The results of the animal studies using the enhanced DehydraTECH formulation showed an increase of CBD delivery into the blood when compared to generic industry MCT coconut-oil formulations by 811%. In addition, the animal studies also showed delivery of 1,937% more CBD into animal brain tissue after 8 hours using the enhanced DehydraTECH technology when compared to generic industry MCT coconut-oil formulations.

Lexaria also has completed the first phases of its collaborative research program with the Canadian government’s National Research Council (the “NRC”) under which several studies were designed to optimize Lexaria’s DehydraTECH technology, enabling delivery of API’s within foods, beverages, capsules and other ingestible formats. These studies investigated the lipophilic active agent classes including cannabinoids, vitamins, NSAIDs and nicotine using advanced analytical techniques, including mass spectrometry and nuclear magnetic resonance testing, with the results of the studies confirming that Lexaria’s DehydraTECH technology did not create any covalent-bonded new molecular entity (“NME”). Whenever an NME is created, regulatory bodies such as FDA and Health Canada routinely require extensive health, safety and efficacy studies prior to that product’s release into the marketplace. That the NRC program failed to find evidence of an NME suggests products utilizing the DehydraTECH technology may require a less burdensome regulatory pathway.

Results from this R&D have helped support B2B relationships with Fortune 500 companies. Lexaria has four distinct subsidiaries that focus on different market sectors: hemp/CBD; pharmaceutical; cannabis; and nicotine. In August 2019, Lexaria was issued its cannabis research and development licence from Health Canada which will allow Lexaria to continue its further investigations in-house of its DehydraTECH technology in connection with cannabinoids, along with ongoing work with vitamins, NSAIDs, PDE5-inhibitors, nicotine and other molecules.

Aside from testing, a critical component of Lexaria Bioscience’s business model is a strong and growing intellectual property portfolio. As of the August 2019, the company’s patent portfolio includes ~60 patent applications filed and pending in more than 40 countries around the world; and 16 patents granted to date. Lexaria is expecting additional new patent awards both in the U.S. and internationally by the end of 2019 and beyond. Some of its more recent areas of investigation have included human hormones and erectile dysfunction substances, among others. Lexaria’s granted patent portfolio related to cannabinoid delivery is one of the largest in the world.

Royalties play a vital role in Lexaria’s revenue-generating business model. The company out-licenses its technology to third-partners and has signed licensing agreements with start-up companies as well as with a Fortune 100 industry leader. The company’s growth initiatives are guided by a management team headed by CEO Chris Bunka, a serial entrepreneur who has contributed to several multi-hundred million-dollar valuations over the course of his career. He is supported by a growing team of professionals with extensive experience in pharmaceutical and bioscience sectors, invention, toxicology, consumer goods and other relevant skillsets.

Lexaria Bioscience Corp. (LXRP), closed Friday's trading session at $0.39405, off by 5.9097%, on 91,376 volume with 45 trades. The average volume for the last 3 months is 99,640 and the stock's 52-week low/high is $0.354999989/$1.6875.

Recent News

Wonderfilm Media Corporation (TSXV: WNDR) (OTC: WDRFF)

The QualityStocks Daily Newsletter would like to spotlight Wonderfilm Media Corporation (OTC: WDRFF).

Wonderfilm Media Corporation (TSXV: WNDR) (OTCQB: WDRFF) announces the availability of a broadcast titled, “Filmmakers Poised for Big Gains in Hollywood’s ‘Streaming Wars.” To hear the NetworkNewsWire Audio version, visit: http://nnw.fm/1ifFu. To read the full editorial, visit: http://nnw.fm/yW8XU.

Wonderfilm Media Corporation (TSXV: WNDR) (OTC: WDRFF) main business is the worldwide production of high-quality feature films and episodic television. The Wonder?lm team includes Hollywood veterans who have packaged, produced and delivered several profitable recent films, including “BlacKkKlansman,” “Get Out” and “The Hurt Locker.” Having these individuals on the Wonderfilm team demonstrates the company’s proven access to Academy Award-quality films and upside.

Wonder?lm maintains a continuing $58 million annual production slate to meet the constant and growing need for content worldwide. The company’s risk-averse production process results in predictable and consistent revenue streams.

Soaring demand for content from streaming providers is fueling industry growth. The global media and entertainment market is expected to grow from $1.9 trillion in 2017 to $2.4 trillion in 2022, a five-year CAGR of 4.4%.

The company recently formed Wonderfilm Global, an international film and television sales and distribution joint venture that is expected to generate significant incremental revenue.

Wonderfilm has strong relationships throughout the entertainment industry, which enables cost-effective production budgets and in-demand content creation.

Management Team with Proven Track Records

Kirk Shaw: Over 240 movies and seven television series to his credit. Headed up Canada’s largest independent film and television production company, attaining $100 million revenue two years straight with 8% EBITDA.

Dan Grodnik: Founded Mass Hysteria Entertainment, a publicly traded company, and became its chairman/CEO. Produced over 50 feature films, including “Bobby,” the 2006 Robert Kennedy biographic film.

Shaun Redick & Yvette Yates: $300 million+ USD total production budgets to date with a combined 175 award wins/355 nominations, including 10 Oscar nominations. In 2017 and 2018, they produced two of the most successful Hollywood films of those years: “Get Out” ($255 million USD gross revenue) and “BlacKkKlansman” ($100 million USD gross revenue). Scheduled to produce two to three films per year for Wonderfilm, with the first release slated for October 2020. Committed to the 4% challenge to give more women and women of color the opportunity to direct.

Jeff Bowler: 2017 Emmy Award-winning producer. Vice president of acquisitions and production for The Exchange, one of the top film sales and finance companies in the world. Bowler is the executive for Wonderfilm Global distribution.

Bret Saxon: Through his company, TMP Inc., Saxon created M&A deals worth over US$750 million across 113 countries. Produced several feature films and made-for-television movies, including Wonderfilm’s 2019 movie “Zombie Tidal Wave” for NBC/Universal’s SYFY.

17-Title Movie Slate — Greenlit

Wonderfilm currently has 17 films greenlit with combined budgets totaling $58 million. Wonderfilm production stars include: John Travolta, Nicolas Cage, Guy Pearce, Ryan Phillippe and Anne Heche, to name a few.

Some of the company’s most notable greenlit projects include the horror film “Amityville 1974,” slated for theatrical release in October 2020, and the action film “Inside Game” starring Tyrese Gibson, which will be released to theaters in fall 2020.

The company is also actively developing a number of other new IP projects, including a dramatic biographic feature titled “Life and Times of Steve McQueen,” a film adaptation of the bestselling novel “Merchant of Death” and a television series headed by “CSI: Crime Scene Investigation” creator Anthony Zuiker.

 

Potential for Breakout Success

Wonderfilm movies have the potential for millions of dollars in revenue from the kind of breakout success generated by films like “Saw” and “Get Out,” which would propel Wonderfilm and its revenue streams to a new level. Wonderfilm has several potential breakout films in its development/production queue.

Note: Potential breakout films are not factored into company’s revenue projections.

Base Hits and Home Runs

In tandem with its slate of high-profile films, Wonder?lm continues to finance, produce and deliver many profitable low-risk, lower-budget films that are base hits. Shaun Redick is a home run hitter, and his upcoming Wonderfilm projects are anticipated to be home run hits for the company, while base hits such as “Zombie Tidal Wave” provide a consistent source of revenue.

Recent Industry Breakout Films Include:

  • SAW – $1.2 million budget = $103.9 million in sales
  • Pulp Fiction – $8 million budget = $212 million in sales
  • My Big Fat Greek Wedding – $5 million budget = $250 million in sales
  • Lost in Translation – $4 million budget = $120 million in sales
  • Get Out – $4.5 million budget = $255.5 million sales (Shaun Redick)

Note: Revenue from most of Wonderfilm’s current slate will be recorded on the books in 2020 or 2021.

Recent Wonderfilm Releases

  • Aug. 17, 2019: Co-produced with NBC/Universal, “Zombie Tidal Wave” premièred on the SYFY channel to strong ratings.
  • Aug. 29, 2019: “The Fanatic” starring John Travolta opens in U.S. theaters.
  • Sept. 5, 2019: “Tammy’s Always Dying” premiers at Toronto Film Festival.
  • Nov. 8, 2019: “Primal” starring Nicolas Cage opens in U.S. theaters.

Wonderfilm Global Distribution

At the 2019 Cannes Film Festival, Wonderfilm officially launched Wonderfilm Global, a new film, television and media foreign sales/distribution joint venture with 101 Films and Paul McGowan.

Wonderfilm acquired 51% ownership in the joint venture structure and immediately began attaching its own productions to Wonderfilm Global. The joint venture represents a significant opportunity for Wonderfilm, changing how the company does business.

The intention behind Wonderfilm Global is to keep distribution margins in-house that previously went to other companies. Since most Wonderfilm movies are relatively low-risk and easy to sell because they feature desirable cast and genre, third-party distribution companies were previously earning approximately 10%, plus expenses, on Wonderfilm movies without any level of risk. Now, revenue is generated through presales of Wonder?lm projects and, at times, third-party films. The average Wonder?lm movie is pre-sold for $5million, garnering $500,000 to $750,000 per sale as a commission. These commissions now stay in-house with Wonder?lm Global, and the company expects to sell 10 to 12 third-party films between fall 2019 and fall 2020, generating roughly $6 million in commission income.

A further revenue source is generated from theatrical sales through a 50/50 upside split once the minimum sales threshold is met.

Wonder?lm Global has offices in Vancouver, Beverly Hills, London, Ireland, Seoul and China.

Wonderfilm Business Model

Wonderfilm productions are structured to begin generating a return to the company as soon as the camera starts rolling.

Return Before a Film is Delivered: Producer fee line items are included in each production budget. These range from $50,000 to $500,000, depending on the total budget, and are paid to Wonderfilm most commonly on the first day of principle photography.

Distribution: Wonderfilm Global charges sales and distribution fees within each production budget to cover its presale costs.

Note: Wonderfilm’s productions are all structured to minimize risk by matching budget to funds available.

Return After a Film is Delivered: Unsold presale territories are countries or territories left off of a film’s presale list, either for strategic reasons or because the broadcaster/distributor is waiting to see the completed film. These outside-the-budget distribution sales become Wonderfilm profit centers.

Sales overages once contracted presale threshold is surpassed.

The company’s film library grows with each new production, adding to future sales revenue. Depending on the agreement, exploitation rights for future worldwide sales return to Wonderfilm four or seven years after delivery. As of October 2019, Wonderfilm’s growing film library comprises 18 titles for future exploitation.

Note: The nature of the film business is that box office revenue lags production up to a couple of years.

$50 Million Wonderfilm Production Fund (WPF):

Wonderfilm is in the process of raising $50 million to establish a Wonderfilm Production Fund (WPF). WPF is designed to consolidate traditional production financing models into a single diversified, asset-backed debt instrument.

The WPF is a highly specialized investment vehicle with noncorrelated market returns normally reserved for institutional banks and specialty lenders, and it would pay 8% interest directly from each Wonderfilm movie or series budget and not from corporate funds. These same interest payments are already added to each production budget, as the company currently closes a separate financing for every film. The WPF would significantly streamline Wonderfilm’s production rate, adding revenue more quickly and broadening the yearly production slate.

For fund investors, the WPF is a dedicated production-financing vehicle designed to offer a risk-moderated approach to investing in film finance. The managed process provides structure and reassurance that are normally experienced only when working with an institutional lender that has a dedicated staff and resources.

All projects being financed are for Wonderfilm productions, with the fund collateral fully secured by receivables, including presale contracts, government incentives, or a guarantee from Wonderfilm for any unsecured amounts as may be permitted.

Wonderfilm Media Corporation (OTC: WDRFF), closed Friday's trading session at $0.0859, off by 11.4433%, on 115,362 volume with 19 trades. The average volume for the last 3 months is 48,424 and the stock's 52-week low/high is $0.075099997/$0.452270001.

Recent News

LiveWire Ergogenics Inc. (OTC: LVVV)

The QualityStocks Daily Newsletter would like to spotlight LiveWire Ergogenics Inc. (LVVV).

LiveWire Ergogenics (OTC: LVVV) recently reported considerable net income increases during Q3 2019, including impressive year-over-year (“YoY”) revenue growth. To view the full article, visit http://cnw.fm/Xxq3i.

LiveWire Ergogenics Inc. (OTC: LVVV) is a forward-thinking company specializing in identifying and monetizing current and future trends in the health and wellness industry. The company recognizes significant potential in the multibillion-dollar cannabis industry and operates at the forefront for acquisition and management of licensed cannabis real estate locations and the research, development and commercialization of high-end products for distribution throughout California.

During the past two years, LiveWire has diligently researched, secured, designed and set up several fully compliant and permitted cannabis operations in locations in California, including a state-wide distribution license from the Bureau of Cannabis Control. The company is focused on acquiring compliant real estate properties for cannabis operations and entering into operation agreements and strategic alliances to build teams of carefully selected and vetted operators, horticulturists, extractors, distributors and establish research partnerships. Its current portfolio of cannabis operations consists of the following properties:

PODs and Distribution in Coachella, California

For the past year, LiveWire has operated high-tech, state-of-the-art production structures, or “PODs” for its cannabis nursery business. Coachella is also home to the company’s statewide distribution headquarters. Both entities operate under LiveWire’s majority owned subsidiary, GHC Ventures. The company is currently in the process to strategically centralize all operations at its recently acquired Paso Robles facility, Estrella Ranch.

Estrella Ranch in Paso Robles, California

Through its subsidiary, Estrella Ranch Partners LLC, LiveWire acquired a 265-acre historic ranch property in Paso Robles, Calif. Estrella Ranch has a longstanding history, once owned by George R. Hearst, the eldest grandson of the late William Randolph Hearst, developer of Hearst Communications, and is considered among the finest ranches in California and the gem of the California Central Coast. LiveWire is transforming this property into the world’s first “Estate-Grown Weedery” with plans to develop it into a vertically integrated, high-end cannabis facility and wellness retreat in California. The stunning property, located in the heart of the world renown California wine country, currently houses three spacious residences, storage areas, and elaborate equestrian facilities with four barns and numerous stables. LiveWire is designing a truly unique property that features indoor and outdoor cannabis operations, including large outdoor and indoor cannabis production. Long-range plans include adding teaching and luxury recreational facilities focused on providing a comprehensive and unique cannabis-related retreat experience.

 

The Paso Robles Nursery

LiveWire has begun the build-out and will soon begin production in its 22,000-square-foot secure indoor cannabis nursery facility in Paso Robles, Calif. The project includes the conversion of two existing buildings with sufficient power capacity and abundant water supply. Floor plans include more than 10,000 square feet of canopy devoted to “mother” plants and separate clone storage; additional space has been identified for flowering plants. Within the two buildings, the nursery also contains research and development areas, rooms for cannabis waste and storage, record keeping and staging space, security offices, a conference room and additional designated locations required for permit approval and compliance.

LiveWire has spent significant resources to research and maneuver a complex legal environment and confirm the economic and environmental feasibility of potential LiveWire cannabis operations in different locations throughout the state of California. All LiveWire operations comply with California state law and local ordinances. To fully capitalize on these highly valuable assets, LiveWire is seeking funding to accelerate the development of its business plan.

GHC Ventures Subsidiary

GHC Ventures, LiveWire’s Coachella-based distribution division, employs a consumer-driven market approach that provides retailers access to a wide range of new high-end cannabis products, all serviced through the licensed and reliable GHC supply chain and distribution network.

GHC Ventures’ distribution network is available exclusively to licensed manufacturers that pass LiveWire’s stringent legal and environmental qualification process. This enables LiveWire to provide a large and solidly structured legal distribution network for all qualifying third-party operators in California. LiveWire is actively seeking to work with licensed operators who are enthusiastic and qualified to ensure the delivery of high-caliber and legal cannabis products for the fast-growing California medical and recreational cannabis markets.

Research Partnerships

LiveWire has established two independent research teams with world-renowned experts in their respective fields to pursue application of cannabis derivatives to specific targeted medical ailments. The company is also establishing research partnerships to explore the application of cannabinoid-based products to target specific ailments or conditions with large “sufferer” populations for both human and veterinarian applications. Possible applications may include dosing verification of zero-pesticide products for quality brands via its 7X Pure Cannabis Dosing and Verification System.

LiveWire has also engaged a highly qualified research team and advisory board to explore the opportunities in the unexplored yet highly valued equine space. The company has entered into consulting and/or advisory board agreements with high-caliber individuals from the medical and international-performance equine sector and is currently exploring strategic relationships with the veterinary departments of leading local and domestic universities and medical facilities.

7X Pure™ Dosing and Verification System

LiveWire Ergogenics is developing its “7X Pure Compliance and Dosage Verification System” intended to provide third-party verification of cannabis material origin, potency, purity, dosage and labeling, securing each product with a digital identity and clearly identifiable chain of custody.

The 7X Pure system will be completely secure, transparent and verifiable, protecting the confidentiality of growers’ and manufacturers’ intellectual property while providing retailers, consumers, government officials and others verification that the growers’ and manufacturers’ claims are true.

The system is designed as a parallel service to the seed-to-sale data provided by marijuana tracking software, will help growers and manufacturers meet increasing compliance requirements related to logistics, quality and transparency. It will also provide a high level of assurance to everyone from end users to municipalities.

Acquisitions & Operations

To maximize the utilization of its fully compliant locations and the licenses granted throughout California, LiveWire has begun and continues to pursue acquisitions of and/or strategic alliances with qualified cannabis companies and consultants. LiveWire will apply a strict regimen to the acquisition of operators, carefully utilizing its experience and legal standing in the California cannabis market for the selection of qualified operators.

Market Opportunity

Legal marijuana is the fastest-growing industry in the United States. Twenty-nine states have already legalized medical marijuana, eight states have approved it for recreational use, and more are following suit. Once the trend toward legalization expands to all 50 states, marijuana could become larger than the organic food industry, according to a new report obtained by The Huffington Post.

The U.S. marijuana industry is forecast to generate annual revenues ranging from $17 billion to $35 billion by 2021. The combined legal medical and recreational market has grown by roughly 30 percent, reaching $6 billion during 2017, according to The Marijuana Business Factbook. The same study projects the market will increase 300 percent to top $17 billion by 2021. During 2017 recreational sales grew by 80 percent, reaching $1.8 billion, not yet accounting for sales of the biggest revenue producer, California, which will only commence with recreational sales in 2018.

Business Model

LiveWire’s diligent approach to the cannabis sector is based on extensive environmental and legal research to predetermine the feasibility of the locations it selects for operations. The company pursues a carefully selected approach of acquiring, licensing and managing self-contained and permitted real estate properties for the development and distribution of its products and leasing to third party operators. LiveWire avoids the complications and high start-up cost of the typical large “growing” operations, instead focusing on becoming the market leader in research, cloning and verification, producing and distributing high quality brands.

Management Team

LiveWire’s team of experienced corporate managers and innovators are leading the company’s plans to capture increasing market share from different and often underserved market sectors in the cannabis industry. LiveWire intends to utilize its team’s experience to accelerate the development and/or acquisition of new properties, product offerings, and companies.

Bill Hodson, CEO & Chairman of the Board
Bill Hodson is responsible for the strategic direction of the firm’s development, branding, sales and marketing strategies. In addition to being responsible for the operation of the company, he leads the development and manages implementation of the company’s innovative product strategy. Previously the executive vice president of LiveWire Sports Group, Hodson was responsible for overseeing all LiveWire’s operations, including the launch of several sports publications and one of the country’s largest sports consumer expos.

As early as five years ago, Hodson recognized the potential of CBD and became an early adopter of CBD as a health and wellness supplement by including hemp-derived cannabidiol in a starburst size edible product. His experience includes not only product development, marketing and sales, but most significantly constant city and county advocacy, guiding the company through four license processes, identifying and spearheading real estate acquisitions, and to assemble operations teams comprised of nursery horticulturists, cultivators and distribution personnel. His vision for the industry is complimented with his out-of-the-box thinking and anticipation of positioning for the future.

Kyle McKay, Horticulturist
Kyle McKay is responsible for managing LiveWire’s controlled cultivation environment, developing new-age genetics to produce consistent and high-quality products for medical patients, and applying his expertise in integrated pest management with Omri-certified fungicides and pesticides. McKay oversees the company’s clone development and supervises both cultivation facilities in Coachella and Paso Robles. He also assists with location research and selection; cultivation center planning; operations set-up; and maximizing the growth potential of cannabis edibles, concentrates and oil production. McKay’s expertise in plant genetics and modern horticulture technology makes him extremely qualified to guide LiveWire’s efforts. During his 12-plus years in the cannabis horticulture field, he has grown more than 230 stable genetics, managed over 27 cultivation centers and grown the specific strains required to meet the needs of up to 45,000 medical cannabis patients at one time.

Advisory Board

Jeff Halloran, Investment Banker
Jeff Halloran is an accomplished senior-management executive with more than 35 years of experience. He has founded and held top positions in large financial and technology firms and has an outstanding record of achievement managing multimillion and billion-dollar programs. Halloran will use his standing in the Canadian markets to provide LiveWire with research and advice for potential acquisitions and strategic alliance targets in the burgeoning Canadian cannabis markets. Halloran has spent most of his career in leading management and consulting positions gathering extensive knowledge in strategic business analysis and information management theories. He served as managing director of Avalon Capital and Halloran Investment, as well as chairman and/or CEO of several companies owned by MT Dynamics. As a consulting manager he was recruited by Oracle Corporation to establish the multibillion-dollar organization’s consulting practice in Canada, eventually earning a place on the design team for Oracle Financials and its CASE Tool and Methodology. Halloran also heads up the executive committee for the Willow Breast Cancer Support Organization.

Michael Corrigan, Attorney at Law
Michael Corrigan is a legal professional at the Law Offices of Michael L. Corrigan, practicing in San Diego, Calif. His practice emphasizes general and SEC representation of emerging high-technology and other operating companies. He has been counsel to private and public companies in a broad range of industries, including computer hardware and software, telecommunications, multimedia and cannabis.

Matthew Geriak, Clinical Pharmacist and Investigational Research Pharmacist
Matthew Geriak is a specialized pharmacist and has a system-wide position on the Investigational Review Board for Sharp Healthcare, which owns five hospitals and various clinics throughout San Diego County. Sharp conducts drug research spanning from phase 1 to 4 human research clinical trials focusing on the fields of oncology, renal and heart transplantations, septic shock treatment, infectious diseases and anticoagulation. Geriak is the primary investigator for retrospective cohorts in the field of infectious diseases.

Jimmy Connors, Sports Industry Adviser
Jimmy Connors is a legendary No. 1 ranked tennis player and is considered among the greatest in the history of the sport. Today, Connors still holds three prominent Open Era Men’s singles records: 109 titles, 1,535 matches played, and 1,256 matches won. His titles include eight?majors, five U.S. Opens, two Wimbledons, one Australian Open, three year-end championships and 17?Grand Prix Super Series. Connors brings a wealth of knowledge in the sports and wellness industries that will be especially important as LiveWire expands into its next phase of development with its topical products. His decade-long exposure in the global sports world as one of the most recognized personalities adds a high level of exposure and supports LiveWire’s efforts to set itself apart in a fast-growing and still turbulent and disruptive industry.

LiveWire Ergogenics Inc. (OTC: LVVV), closed Friday's trading session at $0.0065, off by 3.7037%, on 285,386 volume with 16 trades. The average volume for the last 3 months is 1,198,996 and the stock's 52-week low/high is $0.0035/$0.037399999.

Recent News

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

ActionStockPicksAgressive StocksBetting On Wall StreetCannabisNewsWireGot Stocks?Got Stock Tips?Green Car StocksGreen Energy StocksGreen On The StreetHomeRunStocksMissionIRMissionIR MediaMissionPRMissionSMRNetworkNewsWireQualityStocks MediaQStocksQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsStock BeatsStocks To Buy NowTerrificStocksTiny GemsTip.usTouchdownStocksDaily ToutTraderPower

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.